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7ABSTRACT
The members of the genus Lactobacillus belong to the heterogeneous group of lactic acid
bacteria (LAB), Gram-positive bacteria that have been widely utilized for centuries in the
food and feed industry. Like many other bacteria, several species of Lactobacillus have a
surface (S-) layer as the outermost component of the cell. The thus far characterized functions
of Lactobacillus S-layers are involved in mediating adhesion to different host tissues.
In this study, the S-layer proteins of two Lactobacillus brevis strains, neotype strain
ATCC 14869 and ATCC 8287, were investigated with respect to their gene expression and
applications related to more efficient mucosal antigen delivery, respectively. The S-layer proteins
of L. brevis could be utilized as putative antigen carriers and the SlpA protein of L. brevis
ATCC 8287 was studied in this respect. Two new S-layer proteins (SlpB and SlpD), with
potential to be tested as antigen carriers, were characterized and three slp genes (slpB, slpC
and slpD) were isolated, sequenced and their expression examined from Lactobacillus brevis
ATCC 14869. Under different growth conditions, L. brevis ATCC 14869 was found to form
two colony types, smooth (S) and rough (R), and by a mechanism not involving DNA
rearrangements to differently express the S-proteins. In the L. brevis ATCC 8287 SlpA protein,
a poliovirus epitope VP1 and a c-Myc epitope from the human c-myc proto-oncogene were
surface displayed in a chimeric form. One of the four insertion sites, allowing the best surface
expression determined with the VP1 constructs, was used for the construction of an integration
vector carrying the gene region encoding the c-Myc epitopes. As a result of successful gene
replacement, an L. brevis integrant was obtained that displayed the c-Myc epitope in all of the
S-layer protein subunits without any effect on the S-layer lattice structure, demonstrating that
at least small epitopes can be successfully surface-displayed as part of the S-layer protein of
L. brevis.
To study whether a naturally nonadhesive lactic acid bacterium can be rendered adhesive,
the receptor-binding region of the L. brevis ATCC 8287 SlpA was surface displayed in
Lactococcus lactis with a cassette additionally encoding a proteinase spacer and an autolysin
anchor. The lactococcal transformants were indeed able to bind to a human intestinal epithelial
cell line, Intestine 407, and also to fibronectin, demonstrating the functionality of the receptor-
binding region of the SlpA in a heterologous LAB host.
In addition to antigen carriers, the expression of a putative vaccine adjuvant in L. lactis
was studied. As cytokines are currently being considered as adjuvants, porcine interleukin-2
was chosen for this study. Two secretion cassettes were constructed in which the secretion
was achieved by gene fusion between the lactococcal usp45 secretion signal, a synthetic
propeptide and the sequence encoding the mature IL-2. In addition, one of the two secretion
cassettes contained the H-domains of L. lactis PrtP. Both of the constructed recombinant IL-
2 proteins were found to be secreted in the same quantities and the specific biological activities
of both purified rIL-2 proteins were found to be of similar levels. The expression system for
porcine IL-2 in L. lactis developed in this study can thus be utilized for the production of
biologically-active porcine IL-2, suitable for adjuvant use in future immunization studies.
Abstract
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1. INTRODUCTION
The lactic acid bacteria (LAB) family is composed of a heterogeneous group of Gram-positive,
nonsporing, catalase and cytochrome negative, anaerobic or aerotolent bacteria (Axelsson,
1998). LAB can be divided into homofermentative, heterofermentative and facultatively
heterofermentative according to the end products of their sugar metabolism (Kandler and
Weiss, 1986). In nature, LAB have several different habitats including plant surfaces, decaying
plant material and the mammalian intestine, vagina and oral cavity, which provide the multiple
nutrients required by these fastidious bacteria (Axelsson, 1998). The food and feed industry
widely utilizes LAB in the fermentation of vegetables, silage, and dairy and meat products.
Certain LAB can also act as spoilage organisms in foods such as meat (Borch et al., 1996),
fish (Lyhs et al., 2001) and beverages (Sakamoto and Konings, 2003). Due to their long-
standing industrial use and lack of pathogenicity, LAB are generally recognized as safe (GRAS)
organisms. Several bacteria belonging to the LAB family have been shown to possess beneficial
health-promoting effects to their host and have thus been named as probiotic bacteria (Fuller,
1989), which are currently used in several products intended for both human and animal
consumption. Attention has recently also focused on the development of LAB, especially
lactobacilli, lactococci and streptococci, as antigen delivery vehicles (Lee, 2003; Seegers,
2002; Xin et al., 2003).
Crystalline bacterial surface layers (S-layers) composed of protein or glycoprotein subunits
are present in almost all archaea and all major phylogenetic groups of bacteria as the outermost
structure of the cell envelope (Sleytr and Messner, 1983). Thus far, lactobacilli are the only
LAB from which S-layers have been identified. S-layer proteins represent 10 to 15% of the
total protein of the bacterial cell and are thus the most abundant of all bacterial cellular proteins
(Boot and Pouwels 1996; Messner and Sleytr, 1992). The S-layer subunits are non-covalently
linked to each other and to the supporting cell envelope (Sára, 2001). Diverse functions have
been proposed for S-layers, such as acting as protective coats, cell shape determinants, adhesion
sites for exoenzymes, adhesins and virulence factors in pathogenic organisms; however, a
general function for all S-layers has not been determined (Sára and Sleytr, 2000).
 Mucosal surfaces provide the principle portals of entry for most of the viral, bacterial
and parasitic agents (Erikson and Holmgren et al., 2002). Mucosal immunity thus has an
essential role in the prevention of initial infections at the mucosal surfaces. This is reflected in
the fact that the majority of the lymphoid tissues are distributed along mucous membranes,
the gastrointestinal tissues occupying over 80% of them (Takahashi and Kiyono, 1999). Mucosal
surfaces are protected by both innate and adaptive immune defense mechanisms. Adaptive
immune responses are to a large extent mediated by immunoglobulin A (IgA), which is the
predominant antibody in the mucosal secretions (Lamm, 1997).
Introduction
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The development of new mucosal vaccines for the prevention of mucosal infections has
gained much interest recently in modern vaccinology. Live bacterial vaccine vectors studied
for the delivery of antigens to mucosal surfaces include several species of LAB. The use of
LAB as vaccine vectors offers many potential advantages over the use of delivery systems
based on attenuated variants of pathogens, which have also been widely studied (Mercenier et
al., 2000). From the encouraging results obtained from immunization studies conducted with
LAB vaccine carriers it can be concluded that commercial LAB vaccines will eventually also
be on the market, although many areas of the vaccine development still require optimization
as well as a deeper under-standing of mucosal immunology comprising the gut immune system
as the major component.
Introduction
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2. REVIEW OF THE LITERATURE
2.1. Surface-layer proteins
2.1.1. Structure of S-layer proteins
S-layers are monomolecular crystalline arrays identified in hundreds of different species
from the domains of Bacteria and Archaea as the outermost structure of the cell envelope
(Messner and Sleytr, 1992; Sára and Sleytr, 2000). Most S-layers consist of single
proteinaceous subunits with molecular weights of 40 to 200 kDa (Sleytr and Messner,
1983). A few organisms, including Clostridium difficile and Bacillus anthracis, have an
S-layer protein consisting of two types of S-layer subunits (Etienne-Toumelin et al.,
1995; Mesnage et al., 1997; Takeoka et al., 1999). Some Gram-positive and Gram-negative
bacteria produce two superimposed S-layer lattices consisting of different subunit species
(Kist and Murray, 1984; Yamada et al., 1981).
Currently, two types of post-translational modifications of S-layer subunits have
been identified. Glycosylated S-layer proteins have been characterized in Gram-positive
bacteria and in Archaea (Schäffer and Messner, 2001). The glycan chains are typically
composed of two to six monosaccharides repeated up to 50 units consisting of neutral
hexoses, deoxy sugars, amino sugars and in some cases of non-carbohydrate substituents
(Schäffer et al., 1996; Schäffer and Messner, 2001; 2004). The sugar residues of the S-
layer glycoproteins are attached to the protein moiety via O-glycosidic or N-glycosidic
linkages (Schäffer and Messner, 2004). So far, only one report of a phosporylated S-
layer protein exists. The S-layer protein AhsA of Aeromonas hydrophila is phosphorylated
at its tyrosine residues and preliminary results suggest that S-layer phosporylation is a
common feature of other motile aeromonads with S-layers (Thomas and Trust, 1995a).
 The S-layer is usually 5 to 25 nm thick consisting of subunits aligned in lattices
with oblique, square or hexagonal symmetry (Sleytr and Beveridge, 1999; Sára and Sleytr,
2000). The centre-to-centre spacings of the morphological units vary from 3 to 30 nm
(Sleytr et al., 1994). Due to the composition of identical subunits, the pores in the S-layer
proteins also exhibit morphological identity, although the pore size in an individual lattice
can show some variability (Sleytr and Messner, 1988). The porosity of the S-layer protein
surface area can be up to 70% (Sára and Sleytr, 2000).
The S-layer proteins are among the most abundant bacterial proteins, representing
10 to 15% of the total cellular protein of the bacterial cell (Boot and Pouwels, 1996). The
S-layer lattices have been shown to cover the cell surface completely during all stages of
growth (Sleytr and Messner, 1983). Amino acid analyses of S-layer proteins has revealed
some general features in amino acid composition, but the sequence identities among S-
layer proteins of different species or strains within a species are usually very low. The S-
layer proteins have a high content of acidic and hydrophobic amino acids (aa) and few or
no sulphur-containing aa (Messner and Sleytr, 1988; Sleytr and Beveridge, 1999). The
theoretical isoelectric points (pI) of S-layer proteins are usually weakly acidic (Sára and
Sleytr, 2000); Methanothermus fervidus and lactobacilli, however, possess S-layer proteins
with a basic pI (Boot and Pouwels, 1996; Bröckel et al., 1991). Secondary structure
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measurements indicate that in most S-layers 40% of the amino acids occur as β-sheets
and 10-20% as α-helices (Sleytr et al., 2001).
2.1.2. Expression of S-layer protein genes
The large number of S-layer protein subunits, 5  × 105, needed to cover the bacterial cell
indicates efficient gene expression, S-layer protein synthesis and secretion (Boot and
Pouwels, 1996; Sleytr, 1997). In most studied organisms the quantity of S-layer proteins
detected in growth medium is miniscule, indicating a strict control of S-layer protein
synthesis (Messner and Sleytr, 1992). Only a few organisms produce an excess of S-
layer proteins shed into the growth medium, but in Bacillus spp. this seems to occur
commonly (Sidhu and Olsen, 1997). In Bacillus thuringiensis, free S-layer fragments
have only been detected in cell cultures in late-exponential and stationary growth phases
(Luckevich and Beveridge, 1989).
The S-layer protein genes are preceded by single or multiple promoters. The use of
multiple promoters in transcription may lead to higher messenger ribonucleic acid (mRNA)
levels compared to the use of a single promoter and provides the bacterium with the
opportunity to regulate S-protein gene expression by activating the promoters differentially
according to the prevailing physiological conditions (Boot and Pouwels, 1996). In all
bacteria studied thus far, the half-lives of mRNAs encoding the S-layer proteins have
been relatively long, 10 – 22 min, this stability probably contributing to the efficient
production of S-layer protein subunits needed by the bacterium (Boot et al., 1996; Chu et
al., 1993; Fisher et al., 1988; Kahala et al., 1997).
2.1.3. S-layer proteins of lactic acid bacteria
Among the lactic acid bacteria, S-layers have been found from numerous species of the
genus Lactobacillus (Masuda, 1992; Masuda and Kawata, 1983; Yasui et al., 1995). Thus
far the S-layer protein encoding genes have been cloned and sequenced from L. brevis
(Vidgrén et al., 1992), Lactobacillus acidophilus (Boot et al., 1993), Lactobacillus
helveticus (Callegari et al., 1998), and Lactobacillus crispatus (Sillanpää et al., 2000).
Strains of Lactobacillus amylovorus, Lactobacillus gallinarum, Lactobacillus kefir and
Lactobacillus parakefir have also been shown to possess an S-layer (Boot et al., 1996b;
Garrote et al., 2004), but their S-layer protein genes have not yet been sequenced. Although
the study by Boot et al. (1996b) implicated the lack of an S-layer and S-layer protein
encoding genes in strains of Lactobacillus gasseri and Lactobacillus johnsonii, in a recent
study by Ventura et al. (2002) several different strains of these species were shown to
possess two genes encoding surface proteins with typical S-protein characteristics. Two
copies of the S-layer protein gene have also been described for L. crispatus JCM5810
(Sillanpää et al., 2000) and L. acidophilus ATCC 4356 (Boot et al., 1995). In L. crispatus,
the additional S-layer protein gene, cbsB, was not expressed under the tested growth
conditions, whereas in L. acidophilus the silent S-layer protein gene can be expressed
after deoxyribonucleic acid (DNA) rearrangements (Boot et al., 1996c) discussed in detail
in Chapter 2.1.7. Southern blot analyses by Boot et al. (1996b) also suggested the presence
of two S-layer protein genes in L. amylovorus and L. gallinarum.
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The S-layer protein genes of L. brevis and L. acidophilus are preceded by two promoter
sequences (Boot et al., 1996a; Vidgén et al., 1992). The putative S-layer protein gene
apf1 of L. johnsonii and L. gasseri has also been shown to have two transcription start
sites (Ventura et al., 2002). Of the two S-layer promoters in L. acidophilus, only the most
downstream one has been shown to be used to direct the synthesis of S-layer protein
mRNA (Boot et al., 1996a), whereas in L. brevis both promoters are active in all phases
of growth, albeit the transcripts from the most downstream promoter were found to be
predominant in all growth stages (Kahala et al., 1997). The half-lives of the transcripts
encoding the S-layer proteins have been determined for L. acidophilus and L. brevis and
were shown to be 15 min and 14 min, respectively (Boot et al., 1996a; Vidgrén et al.,
1992). From the untranslated leader sequence of the L. acidophilus S-protein mRNA a
hair-pin like secondary structure was identified by computer analysis and was found by
reporter gene analysis to contribute to the efficient production of S-protein (Boot et al.,
1996a). With the aid of the expression and secretion signals of the S-layer protein gene
(slpA) of L. brevis ATCC 8287, high-level heterologous protein production in various
Lactococcus and Lactobacillus hosts has been achieved (Savijoki et al., 1997; Kahala
and Palva, 1999).
The molecular masses of lactobacillar S-layer proteins vary from 43 kDa (Sillanpää
et al., 2000) to 55 kDa (Masuda and Kawata, 1981; 1983), being among the smallest
known for the S-layer proteins. Compared to most other S-layer proteins with acidic
nature, the S-layer proteins of Lactobacillus species differ in having high calculated pI
values (Boot and Pouwels, 1996). The S-layer proteins of some lactobacilli convey
hydrophobicity to the Lactobacillus cell surface (van der Mei et al., 2003) and for one
Lactobacillus strain, L. acidophilus ATCC 4356, the cell surface hydrophobicity has
been shown to change in response to changes in the environmental ionic strength (Vadillo-
Rodríguez et al., 2004).
Sequence alignment studies have revealed that the S-layer proteins of L. acidophilus,
L. crispatus and L. helveticus show the highest homology in the C-terminal one-third of
the proteins (Sillanpää et al., 2000; Smit et al., 2001), whereas no significant homologies
between the S-layer protein of L. brevis and other lactobacillar S-layer proteins have
been described. In L. acidophilus and L. crispatus, the region carrying the information
for the self-assembly of S-layer protein subunits into a regular layer has been shown to
be carried by the N-terminal two-thirds of the protein (Sillanpää et al., 2002; Smit et al.,
2001). The structural organization of the crystallization domain of L. acidophilus S-layer
protein has been studied by Smit et al. (2002) and was concluded to consist of two
subdomains linked by a surface-exposed loop.
The thus far characterized functions of the S-layer proteins in lactobacilli are involved
in mediating adhesion to various extracellular matrix (ECM) proteins and epithelial cells
of both human and animal origin (Table 1). Genetic truncation and heterologous surface
expression studies with Lactobacillus casei have shown that in L. crispatus the collagen-
and laminin-binding domain is located at the N-terminal two thirds of the protein with
almost the same minimal amino acids required for binding to collagen and laminin and
self-assembly (Antikainen et al., 2002; Sillanpää et al., 2000), showing that a single
domain can be multifunctional. In L. brevis, the receptor-binding region was found by in
vitro flagellar display experiments in E. coli, demonstrating that an N-terminal region of
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SlpA, comprising aa residues 96 through 176, mediates the adhesion to human epithelial
cells (Hynönen et al., 2002). Moreover, the binding to fibronectin was also shown to be
mediated by an N-terminal region of SlpA, comprising aa 96 through 245 (Hynönen et
al., 2002).
2.1.4. Secretion of the S-layer proteins
An N-terminal Sec-type secretion signal seems to be typical for S-layer proteins, since
thus far only the S-layer proteins of Campylobacter fetus, Caulobacter crescentus and
Serratia marcescens have been found to be devoid of the signal peptide (SP) (Kawai et
al., 1998; Sára and Sleytr, 2000). The S-layer proteins with N-terminal SPs are secreted
via the general secretory pathway (type II secretion system) (Boot and Pouwels, 1996).
The signal sequences of S-layer proteins typically consist of 20 to 30 amino acids which
are cleaved off after translocation through the plasma membrane yielding the mature S-
layer protein (Sára and Sleytr, 2000). Data concerning the secretion of S-layer proteins
are currently limited, since the reported studies have been carried out with Gram-negative
organisms. The study by Houssin et al. (2002) demonstrated that the translocation of the
Clostridium glutamicum S-layer protein subunits across the plasma membrane is dependent
on proton motive force and ATP (adenosine triphosphate), indicating the involvement of
the Sec apparatus. In A. hydrophila and Aeromonas salmonicida, the S-layer subunits are
translocated across the outer membrane by substrate specific terminal branches of the
general secretory pathway (Noonan and Trust, 1995; Thomas and Trust, 1995b).
The thus far characterized S-layer proteins devoid of an N-terminal SP are secreted
by the Sec-independent type I secretion apparatus (Awram and Smit, 1998; Kawai et al.,
1998; Thompson et al., 1998). In Gram-negative bacteria, the type I pathway most often
recognizes an uncleaved C-terminal secretion signal (Fernández and Berenguer, 2000),
and this is also the case for the S-layer proteins of C. fetus and C. crescentus (Bingle et
al., 1997a; Thompson et al., 1998). From the S-layer protein of S. marcescens, the location
of the S-layer protein secretion signal has not yet been determined (Kawai et al., 1998).
In C. fetus and S. marcescens the genes encoding the components of the secretion system
are located within a single cluster in the vicinity of the S-layer protein-encoding gene
(Kawai et al., Thompson et al., 1998). In C. crescentus, the genes encoding the ABC
transporter and the membrane fusion protein are located immediately downstream of the
S-layer protein encoding gene (Awram and Smit, 1998). Toporowski et al. (2004) have
identified two outer membrane proteins from C. crescentus, RsaFa and RsaFb, which are
both required for full-level secretion of the S-layer protein. Both of these outer membrane
proteins can, however, function alone, leading to decreased secretion levels (Toporowski
et al., 2004). The S-layer protein of S. marcescens is secreted by a LipBCD type I exporter,
which is also involved in secreting other proteins in addition to S-layer proteins (Kawai
et al., 1998).
2.1.5. Attachment of the S-layer protein to the underlying cell envelope
The interactions between S-layer subunits and with the underlying cell envelope
components involve non-covalent linkages that are stronger between the individual
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subunits than those connecting the S-layer lattice to the supporting cell envelope (Sleytr
and Messner, 1983). The S-layer lattices can be disintegrated into their constituent subunits
by different methods. These include the use of chaotropic agents such as urea and guanidine
hydrochloride (Masuda and Kawata, 1980; Takeoka et al., 1991), metal-chelating agents
such as EDTA (Bingle et al., 1987) or high concentrations of salt such as LiCl (Lortal et
al., 1992). Once the disrupting agent used for the isolation of S-layer protein subunits is
removed, the subunits have the ability to spontaneously assemble into regular arrays in
the presence or absence of supporting layers (Sleytr et al., 1993).
Due to the different structural organization of the cell envelope in Gram-positive and
Gram-negative bacteria, the cell envelope part to which the S-layer protein subunits can
attach also differs according to species. However, no general mechanism of attachment
of the S-layer subunit to the cell envelope that would depend on the classification of the
bacterium by Gram staining has been found. Gram-negative bacteria ubiquitously express
a lipopolysaccharide (LPS) component consisting of a lipid A-moiety, core section and
an O-polysaccharide region (Erridge et al., 2002) as a part of the outer membrane. In
several Gram-negative bacteria such as C. fetus, C. crescentus, A. hydrophila and A.
salmonicida, the S-layer protein has been shown to be attached to the LPS (Dooley and
Trust, 1988; Yang et al., 1992; Walker et al., 1994; Garduno et al., 1995). Studies with A.
hydrophila mutant strains have shown that the LPS core oligosaccharide is involved in
S-layer anchoring, whereas studies with A. salmonicida mutant strains have shown that
the anchoring requires the presence of homogeneous-chain-length O-polysaccharide
(Belland and Trust, 1984; Dooley and Trust, 1988). The region responsible for S-layer
attachment to LPS has been shown to reside in the N-terminal part of the S-layer protein
in C. fetus and C. crescentus (Dworkin et al., 1995; Bingle et al., 1997a), whereas in A.
hydrophila the S-layer anchoring domain resides in the C-terminal part of the S-layer
protein (Thomas et al., 1992). From the S-layer protein amino acid sequence of Rickettsia
prowazekii a hypothetical C-terminal hydrophobic anchor has been found (Carl et al.,
1990). Hydrophobic anchor sequences have also been found in some archaeal S-layer
proteins where the S-layer protein is the only cell-wall component and is thus in close
contact with the plasma membrane (Engelhardt and Peters, 1998).
The rigid cell envelope of almost all Gram-positive bacteria is composed of secondary
cell wall polymers (SCWP) such as teichoic acid, lipoteichoic acids, lipoglycans or
teichuronic acids in addition to peptidoglycan (Navarre and Schneewind, 1999; Neuhaus
and Baddiley, 2003). When present in Gram-positive bacteria, the SCWP have been shown
to be responsible for the anchoring of the S-layer protein to the cell envelope through
different mechanisms. The S-layer homologous (SLH) motifs first identified by Lupas et
al. (1994) are present at the N-terminal part of S-layer proteins in several Gram-positive
bacteria and have been found to be responsible for the anchoring of S-layer protein to
SCWP (Brechtel and Bahl, 1999; Chauvaux et al., 1999, Ilk et al., 1999; Mader et al.,
2004; Mesnage et al., 2000; Mesnage et al., 2001). The S-layer proteins usually possess
three repeats of SLH domains, each consisting of about 55 amino acids (Engelhardt and
Peters, 1998). Mesnage et al. (2000) have reported that in B. anthracis the anchoring of
SLH domains to the cell surface involves the addition of a pyruvyl group to a
peptidoglycan-associated polysaccharide fraction and they also suggested that this type
of anchoring could occur in other species of the Bacillus cereus group. However, a single
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SLH domain present in the S-layer protein of Thermus thermophilus, a bacterium of
Gram-negative character having a similar subcellular architecture to Gram-positive
bacteria (Quintela et al., 1995), seems to bind directly to the peptidoglycan (Olabarría et
al., 1996). Structural analyses of the envelope of T. thermophilus have shown that the
peptidoglycan of this bacterium does not contain any associated macromolecules (Quintela
et al., 1995). Several cell-associated exoenzymes and other exoproteins of Gram-positive
bacteria as well as outer membrane proteins of Gram-negative bacteria have also been
shown to possess SLH domains (Engelhardt and Peters, 1998) that seem to have a cell-
surface-anchoring role similar to S-layer protein SLH-domains (Lemaire et al., 1995;
Kosugi et al., 2002).
The S-layer proteins of lactobacilli, Corynebacterium glutamicum and Geobacillus
stearothermophilus wild-type strains belong to a group of S-layer proteins from which
no SLH-domains have been detected (Chami et al., 1997; Engelhardt and Peters, 1998;
Jarosch et al., 2000), but the binding of these S-layer proteins to the cell wall has some
similarities to SLH-domain mediated binding. Masuda and Kawata (1980, 1981, 1985)
examined the attachment of S-layer proteins of L. brevis and Lactobacillus buchneri to
the cell wall and concluded that the binding site for the S-layer proteins in these bacteria
is not peptidoglycan or teichoic acid but a neutral polysaccharide moiety of the cell wall.
The C-terminal regions of the S-layer proteins of L. acidophilus ATCC 4356 and L.
crispatus JCM 5810 are almost identical in sequence, and the cell wall binding domain
in these bacteria has been shown to reside in the C-terminal region (Antikainen et al.,
2002; Smit et al., 2001). Smit and Pouwels (2002) showed that in L. acidophilus an N-
terminal repeat in the C-terminal SAC domain is most likely responsible for the anchoring
of S-layer protein to cell wall fragments. For the S-layer proteins of L. acidophilus and L.
crispatus, teichoic acids have been suggested to be involved in the binding (Antikainen
et al., 2002; Smit and Pouwels, 2002). From the S-layer protein of C. glutamicum a C-
terminal hydrophobic segment involved in the anchoring of the S-layer to the cell wall
has also been found (Chami et al., 1997). However, in C. glutamicum this hydrophobic
domain anchors the S-layer protein to an outer membrane of hydrophobic nature (Bayan
et al., 2003; Chami et al., 1997). Wild-type strains G. stearothermophilus ATCC12980
and PV72/p6 (formerly Bacillus; Nazina et al., 2001) have S-layer proteins with nearly
identical N-terminal regions which in these bacteria are responsible for the anchoring of
the S-layer protein subunits to the secondary cell wall polymer of the cell envelope
(Egelseer et al., 1998; Jarosch et al., 2000). The secondary cell wall polymer, to which
the S-layer protein subunits attach, is of identical chemical composition in both of the G.
stearothermophilus wild-type strains consisting of glucose and N-acetylglucosamine
(Egelseer et al., 1998; Sára et al., 1996).
2.1.6. Functions of S-layer proteins
Diverse functions have been described for the S-layers (Table 1), but no general function
for all S-layers has been found (Sleytr and Beveridge, 1999). In some organisms such as
C. fetus and A. salmonicida S-layers are multifunctional (Table 1), acting as virulence
factors in these pathogens. S-layers act as adhesins in several bacteria such as lactobacilli
and B. cereus, mediating the adherence of these bacteria to epithelial cells and/or ECM
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(Hynönen et al., 2002; Kotiranta et al., 1998; Schneitz et al., 1993; Toba et al., 1995). S-layers
have also been shown to act as adhesion sites for exo-enzymes in G. stearothermophilus spp.
(Egelseer et al., 1995; 1996; Jarosch et al., 2001), protect the cells from predation by Bdellovibrio
bacteriovorus (Koval and Hynes, 1991), function as cell shape determinants (Messner et al.,
1986; Pum et al., 1991), templates for fine-grain mineral formation (Schultze-Lam et al.,
1992) or molecular sieves (Sára and Sleytr, 1987).
2.1.7. S-layer phase variation
Several bacteria, including both pathogens and nonpathogens, have been shown to be
capable of varying their S-layer proteins based on DNA rearrangements. S-layer variation
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Table 1. Organisms possessing S-layers with defined functions.
Bacterium S-layer
protein
Function Reference(s)
Geobacillus. 
stearothermophilus
ATCC 12980 
SbcC Exoamylase-binding site Jarosch et al., 2001 
G. stearothermophilus 
DSM 2358 
High-molecular weight amylase 
binding site 
Egelseer et al., 1995; 
1996 
G. stearothermophilus 
spp.
Molecular sieve Sára and Sleytr, 1987 
Rickettsia prowazekii and 
Rickettsia typhi
Responsible for humoral and cell 
mediated immunity 
Carl and Dasch, 1989 
Resistance to serum-mediated killing 
and phagocytosis 
Blaser et al., 1987; 
1988 
Campylobacter fetus SapA
Virulence factor in infection Blaser and Pei, 1993; 
Grogono-Thomas et 
al., 2000; Pei and 
Blaser, 1990 
Synechococcus Template for fine-grain mineral 
formation 
Schultze-Lam et al., 
1992 
Virulence factor  Ishiguro et al., 1981 
Adhesion to ECM proteins, 
macrophages and non-phagocytic cells 
Doig et al., 1992, 
Garduno et al., 1992; 
2000 
Responsible for humoral and cell-
mediated killing 
Munn et al., 1982 
Aeromonas salmonicida VapA 
Prevents predation by Bdellovibrio 
bacteriovorus
Koval and Hynes, 
1991 
Aquaspirillum spp. Prevents predation by Bdellovibrio 
bacteriovorus
Koval and Hynes, 
1991 
Bacteroides forsythus Virulence factor Sabet et al., 2003 
Bacillus cereus Adhesion to laminin Kotiranta et al., 1998 
Lactobacillus acidophilus Adhesion to avian epithelial cells Schneitz et al., 1993 
Lactobacillus brevis SlpA Adhesion to human epithelial cells and 
fibronectin 
Hynönen et al., 2002 
Lactobacillus crispatus CbsA Adhesion to ECM proteins Toba et al., 1995 
Thermoproteus spp. Determination of cell shape Messner et al., 1986 
Methanocorpusculum 
sinense 
Determination of cell shape and cell 
division 
Pum et al., 1991 
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most often occurs as a response to environmental factors. An example of S-layer variation
thus far only detected at the DNA level is that of L. acidophilus ATCC 4356 (Boot et al.,
1996c). In addition to an actively transcribed S-layer protein gene slpA, L. acidophilus
has a silent slpB gene (Boot et al., 1993; Boot et al., 1995). A 6-kb (kilobase) fragment
contains slpA and slpB genes in opposite orientations and an inversion of this fragment
places the silent slpB gene behind the slpA promoter (Boot et al., 1996). The inversion
most likely occurs by site-specific recombination at a 5´-identity region present in slpA
and slpB, but the inducer for this change has not been determined. In the growth conditions
used only a small minority (0.3%) of the chromosomes had the slpB gene behind the slpA
promoter and the formation of an altered S-protein could not be detected.
The S-layer phase variation detected in G. stearothermophilus sp. is induced by
environmental factors such as oxidative stress and elevated growth temperatures. Under
oxygen-limiting conditions G. stearothermophilus produces S-layer protein SbsA, which
in the presence of an oxygen supply is irreversibly replaced by SbsB resulting in an S-
layer lattice with a different symmetry to that of SlpA (Sára and Sleytr, 1994; Kuen et al.,
1994; 1997).The sbsB gene is located on a natural megaplasmid of strain PV72/p6 and
for the expression of sbsB, the coding region integrates into a chromosomally located
expression site (Scholz et al., 2001). During the switch the sbsA coding region is removed
from the chromosome, leaving only the upstream regulatory region of sbsA in the
chromosome. The switch from sbsA expression to sbsB seems to be irreversible, since no
reversion of the process could be detected. In G. stearothermophilus ATCC 12980 elevated
growth temperatures have been shown to lead to the production of an altered S-layer,
which was found to be glycosylated and encoded by a new gene, slpD, absent from the
chromosome and megaplasmids of the wild-type strain (Egelseer et al., 2001). The S-
layer variation induced by an elevated growth temperature also seems to be an irreversible
process, since no revertants could be detected when the growth temperature of the variant
was reduced to the normal level.
 For B. anthracis, having S-layer protein types Sap and EA1, the modification of the
S-layer protein content of the cell is dependent on the growth phase and conditions. In a
rich medium the B. anthracis cells are covered with a Sap S-layer in the exponential
growth phase, which is is replaced by an EA1 layer in the stationary phase (Mignot et al.,
2002). This S-layer regulation appears to involve Sap and EA1 proteins, which may both
act as transcriptional repressors of the eag gene (Mignot et al., 2002). Sequential expression
of the S-layer genes is not observed when the B. anthracis cells grow in a defined medium
designed to mimic the in vivo conditions that the cells encounter during infection (Mignot
et al., 2003). Under these growth conditions the regulation of the S-layer genes was
found to be controlled by plasmid encoded genes (Mignot et al., 2003).
Wild-type strains of C. fetus have been shown to express S-layer proteins with different
molecular weights with one form predominating for a single strain (Pei et al., 1988).
Each S-layer protein is encoded by promoterless sapA homologue (Dworkin and Blaser,
1996). From the sapA locus only a single promoter can be detected upstream of the sapA
homologue (Tu et al., 2003), and for the expression of sapA homologs only this single
sapA promoter is used (Dworkin and Blaser 1996). Variation in S-layer protein expression
occurs by a single DNA inversion event in which the sapA promoter alone or together
with one or more of the flanking sapA homologs inverts (Dworkin and Blaser, 1996;
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1997). The S-layer variation in C. fetus results in antigenic variation of the S-layer (Garcia
et al., 1995; Wang et al., 1993), thus providing the pathogen a means to delay the host
antibody response, as has been observed to occur in experimentally challenged sheep
(Grogono-Thomas et al., 2003).
2.1.8. S-layer applications and fusion proteins
Due to the highly ordered and regular structure of S-layers and the capability of isolated
S-layer subunits to assemble into regular arrays in suspension, on suitable surfaces or
liquid-surface interfaces, S-layers have a broad spectrum of applications in biotechnology
and nanotechnology (Sleytr et al., 2001; Pum and Sleytr, 1999). These include their use
as isoporous ultrafiltration membranes (Sára et al., 1992) and matrices for immobilization
of functional macromolecules such as antibodies (Breitwieser et al., 1996), allergens
(Bohle et al., 2004) or oligosaccharide haptens (Messner et al., 1992). S-layers can also
be utilized as matrices for the development of dipstick-style immunoassays (Völkel et
al., 2003), templates for the formation of regularly arranged nanoparticles (Mertig et al.,
2001) or as stabilizing structures for solid-supported lipid membranes (Pum and Sleytr,
1999). S-layers also have potential for vaccine development. For the treatment of
furunculosis in fish caused by A. salmonicida, the S-layer protein preparations of A.
salmonicida have been tested (Lund et al., 2003). S-layers also have been studied as
possible vaccine carriers with encouraging results (Jahn-Scmid et al., 1996).
S-layer fusion proteins can be used to study the secretion, cell wall anchoring and
self-assembly of S-layer proteins. They also have several potential applications, including
use as vaccine carriers and functional monomolecular lattices required for applications
in nanobiotechnology. For the construction of the S-layer fusion proteins, the whole S-
layer protein (Bingle et al., 1997b; Umelo-Njaka et al., 2001), a C- or N-terminally
truncated S-layer protein (Breitwieser et al., 2002; Moll et al., 2002) or only the cell
wall-targeting domains (Mesnage et al., 1999b; Smit et al., 2001) can be utilized. The
expression of the S-layer fusion proteins can be plasmid-derived in a heterologous host
(Riedmann et al., 2003; Moll et al., 2002) or a homologous null-mutant host lacking the
wild-type S-protein gene (Bingle et al., 1997b). The S-layer fusion protein can also be
chromosomally encoded (Smit et al., 2002).
The domains involved in secretion and cell wall anchoring of S-layer proteins in
various Gram-negative and Gram-positive bacteria and the adhesion domains of several
lactobacilli have been localized with use of S-layer fusion proteins. The ability of the
SLH motifs of the B. anthracis S-layer proteins EA1 and Sap to mediate cell surface
anchoring has been demonstrated in a study by Mesnage et al. (1999a) in which the SLH
domains were fused with the levansucrase of B. subtilis. A fusion protein consisting of
green fluorescent protein and the SAC domain of the S-layer protein of L. acidophilus
has been shown to bind to Lactobacillus cells stripped of their S-layers, thus demonstrating
the role of the SAC domain in cell wall anchoring of the S-layer protein (Smit et al.,
2001). Linker insertion mutagenesis, resulting in the insertion of four to six amino acids
at different positions in the S-layer protein, RsaA, of C. crescentus, has shown that the
N- terminus is involved in the cell surface anchoring of the S-layer protein and suggested
the presence of a C-terminal secretion signal (Bingle et al., 1997a). With fusion protein
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constructs consisting of a 443-aa exoglucanase enzyme linked to the RsaA C-terminus of
different lengths, the secretion signal could be localized to the C-terminal 82 amino acids
of the RsaA (Bingle et al., 2000). In studying the adhesion of lactobacilli to various ECM
proteins and epithelial cells, whole or truncated S-layer protein genes have been fused
with fliC (Hynönen et al., 2002), the cell wall anchoring sequence of the prtP gene
(Martínez et al., 2000) or histidine tags (Antikainen et al., 2002; Sillanpää et al., 2000).
The self-assembly and lattice formation of S-layer proteins can be studied with S-
layer fusion proteins. By means of linker insertion mutagenesis, inserting a c-myc epitope
at four sites in the S-layer protein, and with his-tagged, truncated S-layer protein fragments,
Smit et al. (2002) have studied the crystallization of the S-layer protein of L. acidophilus.
Insertions in conserved regions or in regions with predicted secondary structural elements
resulted in the absence of crystalline sheets and none of the histidine-tagged, N- or C-
terminally truncated peptides could form regular arrays. The fusion of the major birch
pollen allergen to a C-terminally truncated S-layer protein of G. stearothermophilus has
been shown to result in a fusion protein with the ability to form self-assembly products
with an oblique lattice in vitro and also to recrystallize on native wall sacculi with the
allergen portion located on the outer surface (Breitwieser et al., 2002). A C-terminally
truncated S-layer protein of B. sphaericus has also been used in the construction of S-
layer fusion proteins, and these fusion proteins have been observed to recrystallize into a
regularly structured lattice on cell wall fragments (Ilk et al., 2002; 2004; Pleschberger et
al., 2003), on solid supports coated with SCWP (Pleschberger et al., 2003; Völlenkle et
al., 2004) or on positively charged liposomes (Ilk et al., 2004).
Since the S-layer proteins have been shown to be capable of surface-displaying
even large proteins and different epitopes and they have been shown to possess some
intrinsic adjuvant properties (Jahn-Schmid et al., 1996), S-layers may be utilized as vaccine
vectors. Two immunization studies conducted with B. anthracis strains surface-expressing
either TTFC (tetanus toxin fragment C) or levansucrase with the SLH-domains (Mesnage
et al., 1999b; 1999c) have resulted in a humoral response to the antigen and protection
against tetanus toxin challenge in the TTFC immunized animals. In a study by Riedmann
et al. (2003), immunization with lysed E. coli cells harboring the SbsA protein of G.
stearothermophilus fused with the outer membrane protein (Omp) 26 of Haemophilus
influenzae resulted in a humoral response to the Omp26. Recombinant vaccine candidates
utilizing the S-layer protein, RsaA, of C. crescentus have also been tested. A humoral
response could be obtained against the pilus tip epitope of P. aeruginosa when different
RsaA-pilus tip epitope constructs were used for immunization; however, no significant
protection against a P. aeruginosa infection was obtained (Umelo-Njaka et al., 2001).
Simon et al. (2001) immunized rainbow trout fry with several RsaA-IHNV surface
glycoprotein fusion proteins, but only a limited level of protection was induced against
IHNV challenge.
2.2. The mucosal immune system
Mucosal surfaces are protected against environmental pathogens by both innate and
adaptive immune defense mechanisms. Innate, nonadaptive mechanisms form the early
lines of defence, including physical, chemical, cellular and molecular factors such as the
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movement of mucus by epithelial celia, enzymes secreted by specialized epithelial cells,
the complement system, tissue macrophages and cytokines secreted by activated
macrophages (Janeway et al., 2001). Adaptive immune responses generate antigen-specific
effector cells and eventually an immunological memory against the encountered pathogen.
Adaptive immune responses are mainly achieved by immunoglobulin A (IgA), the
predominant antibody at mucosal surfaces (Lamm, 1997). The sampling of luminal
antigens occurs at the inductive sites of the mucosal immune system, consisting of
organized aggregates of lymphoid cells known as the mucosa-associated lymphoid tissue,
and the immune response operates at effector sites where the lymphoid tissue tends to be
more diffuse (Hathaway and Kraehenbuhl, 2000). The mucosal immune system is distinct
from the systemic immune system, but they are not totally segregated (Hathaway and
Kraehenbuhl, 2000; Takahashi et al., 1999)
2.2.1. Gut immune system
The majority of the body’s mucosal surface area is occupied by the gastroinstestinal
tissues (Takahashi et al., 1999), which encounter a vast array of antigens including invasive
organisms and harmless antigens such as dietary proteins and commensal microbiota
(Stokes and Bailey, 2000). The gut-associated lymphoid tissue (GALT) consists of
inductive sites including Peyer’s patches in the small intestine, isolated lymphoid follicles
scattered throughout the gut lamina propria and mesenteric lymph nodes, and of effector
sites including the lamina propria surrounding Peyer’s patches and lymphocytes scattered
throughout the epithelium (Fagarasan and Honjo, 2003; Mowat, 2003). Only a single
epithelial cell layer lines the entire intestinal mucosal surface separating the gut lumen
from the underlying lymphoid tissue (Spahn and Kucharzik, 2004).
The antigens may gain access to the intestinal immune system by several different
routes (Figure 1). The specialized follicle-associated epithelium overlying Peyer’s patches
and also isolated lymphoid follicles (Fagarasan and Honjo, 2003) contain microfold (also
called membranous; M) cells, which lack the surface microvilli characteristic of small
intestinal epithelial cells and also the surface glycocalyx (Mowat, 2003). The apical surface
of M cells has broad membrane microdomains from where the endocytosis of foreign
antigens or particles occurs; the uptake of antigens may also occur by phagocytosis (Neutra
et al., 1996). The uptaken antigen is transported through the interior of the cell in vesicles
to the basolateral surface, where it is released to the underlying lymphoid tissue. The
basolateral surface of M cells is deeply invaginated, thus facilitating the contact between
the underlying cells of the immune system and the newly transported antigens (Hathaway
and Kraehenbuhl, 2000). Antigens and micro-organisms are usually transported
undegraded and alive across M cells (Neutra et al., 1996), but the exact role of M cells in
the processing and presentation of antigens is not known (Neutra et al., 2001). Several
pathogens such as Salmonella typhi (Pascopella et al., 1995) and reoviruses (Wolf et al.,
1981) preferentially target M cells to gain entry to the body. Reoviruses have been shown
to attach to specific M-cell carbohydrate stuctures (Helander et al., 2003), but because
the glycosylation patterns of M cells vary in different intestinal regions and also in different
species (Neutra et al., 2001), the M cells are able to transport a wide variety of
microorganisms (Neutra et al., 1996).
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Transepithelial transport of antigens may also involve dendritic cells and intestinal
epithelial cells (Figure 1). Dendritic cells have been shown to extend their processes
between epithelial tight junctions and transport both pathogenic and nonpathogenic
bacteria to the lamina propria (Rescigno et al., 2001). The integrity of the epithelial
barrier remains intact during this process because the dendritic cells are capable of re-
forming the tight junctions sealing the apical epithelium, as shown by the regulated
expression of several tight junction proteins (Rescigno et al., 2001). The intestinal epithelial
cells take up antigens by endocytosis, which may be receptor-mediated (Hershberg and
Mayer, 2000). Antigens may also gain entry to the basolateral surface of intestinal epithelial
cells by disrupting the tight junction structure (Nusrat et al., 2001).
Figure 1. Antigen uptake and recognition by CD4+ T-cells in the intestine. Antigen might
enter through M cells in the follicle-associated epithelium overlying Peyer’s patches (a), and
after transfer to local dendritic cells might be presented directly to T-cells in the Peyer’s patch
(b), or alternatively the antigen or antigen-carrying dendritic cells migrate through afferent
lymphatics to the mesenteric lymph node, where T-cell recognition occurs (c). If the antigen
enters through the epithelium covering the villus lamina propria, a similar process of antigen or
antigen-presenting cell dissemination to mesenteric lymph nodes might occur (d), but it is also
possible that the enterocytes act as local antigen presenting cells (e). Antigen might also gain
direct access to the bloodstream from the intestine (f) and interact with T-cells in the peripheral
lymphoid tissues (g). From the mesenteric lymph nodes the antigen-responsive T cells enter the
bloodstream through the thoracic duct and exit into the mucosa through vessels in the lamina
propria or gain access to systemic distribution. DC; dendritic cell, GC; germinal centre. Adapted
from: Mowat, 2003.
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The various possible routes for antigen presentation to naive CD4+ T cells are depicted
in Figure 1. Antigen presenting cells (APC) in the gut can be dendritic cells, macrophages,
B-cells or enterocytes (Makala et al., 2004; Mowat, 2003). Exosome-like vesicles, secreted
by intestinal epithelial cells and bearing high amounts of MHC class I and class II
molecules, have also been suggested to present luminal antigens to immature dendritic
cells (Van Niel et al., 2003). Intestinal epithelial cells have been shown to express major
histocompatibility complex (MHC) class I, II and CD1d molecules, through which the T-
cell interactions may occur (Hershberg and Mayer, 2000). The importance of these
interactions has not yet been established (Makala et al., 2004), but they are probably
limited to pathological conditions such as inflammation (Hershberg and Mayer, 2000).
Dendritic cells are most likely the APC involved in the interactions of naïve lymphocytes
in Peyer’s patches (Mowat 2003). IgA-secreting B cells can also be activated by a T-cell-
independent and follicularly organized lymphoid tissue-independent mechanism, which
has been shown to occur in response to commensal intestinal bacteria (Macpherson et
al., 2000).
The structure of Peyer’s patches (Figure 1) favours strong interactions between B
cells, APC and local CD4+ T cells facilitating B-cell proliferation, class-switch
recombination and somatic hypermutation, which occur in the germinal centres of Peyer´s
patches (Fagarasan and Honjo, 2003) and lead to the preferential generation of IgA+
lymphoblasts (Makala et al., 2002-2003). The IgA+ B cells exit through the draining
lymphatics to the mesenteric lymph nodes, where they proliferate and differentiate into
plasmablasts (Fagarasan and Honjo, 2003). In addition to IgA+ B cells, activated antigen-
specific CD4+ T cells and CD8+ T cells leave the inductive site and are carried via
draining lymph nodes before migration into the bloodstream through the thoracic duct
(Hathaway and Kraehenbuhl, 2000; Takahashi and Kiyono, 1999). Activated lymphocytes
home to the mucosal site from which they originated or to distant mucosal sites (Brandtzaeg
et al., 1999). The homing is mediated by tissue-specific adhesion molecules and
chemokines (Kunkel and Butcher, 2002; Bradtzaeg et al., 1999). The upregulated
expression of adhesion molecule α4β7 integrin in the absence of L-selectin is believed to
be the main determinant for the homing of GALT-derived B and T cells to gut mucosa
(Braentzaeg et al., 1999). The ligand for α4β7 integrin is mucosal addressin cell-adhesion
molecule 1, which is constitutively expressed to endothelium of venules of intestinal
lamina propria (Briskin et al., 1997).
The differentiation of B cell plasmablasts into antibody-secreting plasma cells occurs
in lamina propria (Corthesy and Kraehenbuhl, 1999). IgA+ B cells might also be produced
from IgM+ B cells either in the lamina propria or in the isolated lymphoid follicles scattered
throughout the lamina propria (Fagarasan and Honjo, 2003). The plasma cells of lamina
propria produce enormous amounts of IgA at mucosal surfaces daily (5-10 g), making
IgA the predominant antibody responsible for the humoral immune response in gut
(Corthesy and Kraehenbuhl, 1999; Takahashi and Kiyono, 1999).
Mucosal IgA is typically secreted as a dimeric molecule associated with an intersub-
unit J chain (Lamm, 1997), whereas systemic IgA circulates as a monomer (Nagler-
Anderson, 2001). After binding to the polymeric immunoglobulin receptor present on
the basolateral surface of enterocytes, the IgA is transported by transcytosis to the apical
surface (Rojas and Apodaca, 2002). At the surface, the poly-Ig receptor is enzymatically
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cleaved, separating the external domain from the membrane spanning domain and leaving
the external portion of the receptor bound to the dimeric IgA molecule as the secretory
component (Lamm, 1997). Once transported to the mucosal surfaces, secretory IgA (s-
IgA) antibodies protect the epithelial surfaces from infectious agents by cross-linking
them and thus preventing their attachment to and invasion of the mucosal surface; this
mechanism is termed immune exclusion (Corthesy and Kraehenbuhl, 1999). IgA antibodies
have also been shown to neutralize several viruses intracellularly during transcytosis
(Feng et al., 2000; Mazanek et al., 1995; Yan et al., 2002). An additional defence
mechanism of dimeric IgA includes the transport of IgA-antigen complexes out of the
lamina propria by the same route as free dimeric IgA, limiting the amounts of antigen
reaching the circulation (Kaetzel et al., 1991; Robinson et al., 2001). Pentameric IgM,
the primordial mucosal antibody, can also be secreted at mucosal surfaces by the polymeric
immunoglobulin receptor with the same mechanism as dimeric IgA (Rojas and Apodoca,
2002). IgM is a more potent activator of the complement system than IgA (Lamm, 1997).
Plasma cells also produce IgE antibodies, which have a major role in activating local
mast cells (Corthesy and Kraehenbuhl, 1999). The transcytosis of IgG from the lamina
propria to mucosal secretions, where IgG constitutes a minority of immunoglobulins
(Lamm, 1997), has been suggested to be mediated by the FcRn receptor, capable of
transcytosizing IgG also in the apical-to-basolateral direction (Dickinson et al., 1999).
Oral tolerance is defined as a mechanism of tolerance induction in which prior
administration of the antigen by the oral route renders the mature lymphocytes in the
local and peripheral lymphoid tissues into a state of antigen-specific and active
unresponsiveness (Strobel, 2002). Oral tolerance most likely serves as a mechanism for
the prevention of adverse immune reactions against luminal antigens derived from food
and the commensal gut microbiota (Spahn and Kucharzik, 2004). The precise mechanisms
involved in oral tolerance are still partly unknown (Nagler-Anderson, 2001), and several
mutually non-exclusive mechanisms are likely to occur, depending on the nature and
dose of the antigen, the frequency of antigen administration and several host factors such
as the genetic background, age and the commensal microbiota (Strobel and Mowat, 1998).
The primary mechanisms by which tolerance may be mediated are clonal anergy
characterized by the inability of antigen-specific T cells to proliferate (Sun et al., 2003)
and by the reduction in Th1 specific cytokines (Melamed and Friedman, 1994), deletion
of antigen-specific T cells via apoptosis (Chen et al., 1995) and active suppression by
special regulatory T cells secreting down-regulating cytokines (Chen et al., 1994). The
precise location of intestinal antigen presentation for induction of oral tolerance has not
been clearly determined (Spahn and Kucharzik, 2004), but enterocytes and dendritic
cells have been suggested to be antigen presenting cells involved in the induction of oral
tolerance (Strobel, 2002).
2.3. Lactic acid bacteria as vaccine delivery vectors
Vaccination represents one of the most efficient tools for the prevention and even
eradication of infectious diseases. Since the majority of infections occur at or through
the mucosal surfaces, the use of a mucosal route of vaccination instead of a parenteral
route would be preferable (Holmgren et al., 2003). Compared with the parenteral route
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of vaccination, mucosal vaccination offers several advantages, such as prevention of the
initial infection and replication of the pathogen at the site of entry, stimulation of both
local and systemic immune responses, easy administration and low delivery costs (Medina
and Guzmán, 2001). The key factor in inducing an active immune response at mucosal
sites is the delivery system of the antigen, the development of which is under active
research.
Several strategies have been employed for the mucosal delivery of antigens, including
the use of synthetic (non-living) delivery systems such as liposomes (Ninomya et al.,
2002) or immune stimulating complexes (van Pinxteren et al., 1999), virus-like particles
(Takamura et al., 2004), bacterial vectors (Mielcarek et al., 2001), and genetically
engineered plants (Sala et al., 2003). Widely studied micro-organisms as vaccine carriers
are attenuated variants of pathogens including Salmonella, Shigella and Mycobacterium
(Mielcarek et al., 2001), but the potential risks associated with the use of attenuated
pathogens as vaccine carriers necessitate the development of alternative antigen delivery
systems. Lactic acid bacteria have in recent years attracted considerable attention in the
field of mucosal vaccine research. Several benefits associated with LAB favour their use
as vaccine delivery vehicles. These benefits include the GRAS status of LAB (Adams
and Marteau, 1995), the long-term experience of their production in the food industry,
the capacity of numerous strains to adhere and colonize to mucosal surfaces, beneficial
health-effects for the hosts of several strains, intrinsic immunogenicity, resistance to bile
acid, lack of lipopolysaccharides in their cell wall eliminating the risk of an endotoxic
shock, and the capability to modulate the immune responses obtained by inducing cytokine
production of the host (Mercenier et al., 2000; Pouwels et al., 1998; Seegers et al., 2002).
LAB have been utilized in targeting antigens to the gut, the oro-nasal cavity and the
vagina for the induction of local as well as systemic immune responses (Mercenier et al.,
2000). The LAB strains currently studied and evaluated as antigen delivery vehicles
include L. lactis, Streptococcus gordonii and several Lactobacillus species.
2.3.1. Expression and cellular targeting of heterologous antigens in LAB
Several systems have been developed and tested in LAB for the differential expression
of antigens resulting in cytoplasmic, extracellular medium or cell surface targeting of
antigens. Replicative plasmids (Bermúdez-Humarán et al., 2002; Oliveira et al., 2003) or
chromosomal integration (Oggioni et al., 1999; Smit et al., 2002; Turner and Giffard,
1999) can be utilized for the expression of antigens in LAB. Plasmid-based expression
systems are easier to manipulate than integration systems and are thus more widely used,
although integration systems allow a more stable expression of antigens (Seegers, 2002).
When replicative plasmids are used for antigen expression, one of the key factors in
determining the level of heterologous protein production is the promoter used in controlling
the antigen expression. Promoters used for the expression of heterologous antigens in
LAB can allow either constitutive or inducible expression. Constitutive promoters used
in LAB for the expression of antigens or medically interesting proteins include L. lactis
derived promoters P59 (Dieye et al., 2003), P23 (Chang et al., 2003), and P1 (Schotte et al.,
2000), P25 of Streptococcus thermophilus (Hols et al., 1997), and Pldh of L. casei (Zegers
et al., 1999). To avoid possible harmful effects to the cell resulting from continuous high
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level production of antigens, several inducible expression systems have been developed.
The most widely used inducible expression system in LAB is the nisin-inducible system,
which has been used both in lactococci (Bermúdez-Humarán et al., 2003a; Cortez-Perez
et al., 2003; Enouf et al., 2001; Ribeiro et al., 2002) and in lactobasilli (Pavan et al.,
2000). The nisin-inducible system was originally developed for L. lactis and is based on
the autoregulatory properties of the nisin gene cluster (de Ruyter et al., 1996a; 1996b).
Transcription of the genes under the nisA promoter can be induced by nisin, mediated by
a two-component regulatory system consisting of the histidine kinase NisK and response
regulator NisR (Kuipers et al., 1995; van der Meer et al., 1993). Other controllable
expression systems utilized for antigen expression in LAB include the Plac of L. casei
(Oliveira et al., 2003), Pamy of L. amylovorus (Maassen et al., 2003) and P170 of L. lactis
(Theisen et al., 2004).
When cytoplasmic production of antigens is desired, in addition to a promoter
sequence, a ribosome binding site and the start of an open reading frame are required for
protein synthesis to occur. Extracellular and cell-surface located production of antigens
additionally requires a SP for the translocation to occur. Signal peptides used in LAB for
the translocation of heterologous proteins and antigens across the plasma membrane
include the SP Usp45 from the main secreted protein in L. lactis (Dieye et al., 2001;
Lindholm et al., 2004; Ribeiro et al., 2002), the SP of the fibrillar surface protein M6 of
Streptococcus pyogenes (Hols et al., 1997; Piard et al., 1997), the SP of the α-amylase of
L. casei (Shaw et al., 2000), SPs of the cell surface proteinases of L. lactis (Slos et al.,
1998), and Lactobacillus spp. (Bernasconi et al., 2002; Maassen et al., 1999), SPs from
different S-layer proteins (Chang et al., 2003; Lindholm et al., 2004), SP310 of L. lactis
and its derivatives (Ravn et al., 2003; Theisen et al., 2004), and the SP of Staphylococcus
aureus Nuc protein (Chatel et al., 2003), which all utilize the sec-dependent secretion
machinery of the host bacterium. The secretion efficiency of several heterologous proteins
produced by lactococci has been improved by inserting a synthetic propeptide
LEISSTCDA between the SP cleavage site and the mature moiety of the heterologous
protein to be exported (Bermúdez-Humarán et al., 2003a; Langella and Le Loir, 1999;
Ribeiro et al., 2002). The synthetic propeptide LEISSTCDA alters the N terminus of the
mature protein by introducing negative charges on the protein at positions +2 and +8.
The LEISSTCDA propeptide can potentially optimize the charge balance between the N-
termini of the precursor and the mature protein and/or affect precursor conformation,
thus leading to the enhancement of precursor translocation and processing (Le Loir et al.,
1998). The expression of heterologous proteins in L. lactis has also been stabilized by
using a host strain defective in HtrA (Miyoshi et al., 2002; Poquet et al., 2000), an
extracellular protease degrading abnormal exported proteins (Poquet et al., 2000).
The cell-surface located production of antigens by LAB can involve several strategies.
The most widely exploited method for targeting heterologous proteins to the cell wall in
LAB is the utilization of a C-terminal cell wall anchor domain, consisting of a conserved
LPXTG motif, a transmembrane fragment and a charged C terminus (Leenhouts et al.,
1999). A transpeptidation reaction between the LPXTG motif and peptidoglycan attaches
the exported protein to the cell wall by the action of sortase machinery (Navarre and
Schneewind et al., 1999). Anchoring of several antigens and other heterologous proteins
in diverse LAB species using the LPXTG-motif anchor of protein M6 of S. pyogenes
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(Byrd et al., 2002; Cortes-Perez et al., 2003; Reveneau et al., 2002), PrtP proteins of L.
paracasei (Maassen et al., 1999) and L. lactis (Lindholm et al., 2004), Rlp protein of
Lactobacillus fermentum (Turner et al., 2003) and protein A of S. aureus (Steidler et al.,
1998) has been achieved. Another type of anchor domain utilized thus far only in lactococci
for the surface display of heterologous proteins includes the use of the C-terminal region
of cell wall hydrolase AcmA of L. lactis (Lindholm et al., 2004). The AcmA anchor
domain, consisting of three highly homologous repeats of 45 aa, binds to the peptidoglycan
by an unidentified mechanism (Steen et al., 2003), suggested to be of a non-covalent
nature (Leenhouts et al., 1999). Other modes of anchoring antigens or other heterologous
proteins to the surface of LAB include the use S-layer proteins of lactobacilli (discussed
in chapter 2.1.7.), the use of a non-covalently anchored BspA protein of L. fermentum
(Turner and Giffard, 1999; Turner et al., 2003) and the use of a lipoprotein or
transmembrane anchors (Leenhouts et al., 1999).
2.3.2. Lactococcus lactis as a vaccine vector
A LAB species intensively studied as a possible vaccine delivery vehicle is L. lactis, a
bacterium which does not colonize the oral or intestinal cavities of humans or other
animals (Wells et al., 1996). In mice (Kimoto et al., 2003) and humans (Klijn et al., 1995)
the passage of lactococci through the enteric tract is transitory, the survival rate being
only 1% in humans (Klijn et al., 1995). Lactococci administered together with food have
been shown to be relatively resistant to gastric acidity, viable cells retaining their metabolic
activity all the way through the digestive tract of rats (Drouault et al., 1999). Due to the
limited capacity of lactococci to produce antigens in vivo in the gut, preloading of the
bacteria with antigen before delivery would be desirable. This necessitates the use of
expression systems leading to high-level expression of the antigen. Indeed, intracellular
antigen production levels representing up to 22% of total soluble cell proteins (Wells et
al., 1993) have been achieved in lactococci.
Several antigens of bacterial (Iwaki et al., 1990), viral (Dieye et al., 2003), and
eukaryotic (Chatel et al., 2003) origin have been produced in L. lactis. Tetanus toxin
fragment C (TTFC), a model antigen with high immunogenicity, consisting of a
monomeric, non-toxic subunit of the tetanus toxin of Clostridium tetani (Mercenier et
al., 2000), is the most widely studied antigen in the context of  Lactococcus vaccine
delivery systems. The use of Lactococcus as a cytokine delivery vehicle has recently
also gained considerable attention. Steidler et al. (1995) first described the secretion of a
biologically active cytokine in L. lactis, murine interleukin-2, and to date several additional
cytokines of murine (Bermúdez-Humarán et al., 2003c; Schotte et al., 2000; Steidler et
al., 1998a), ovine (Bermúdez-Humarán et al., 2003b) and human (Steidler et al., 2003)
origin have been produced intra- or extracellularly by Lactococcus. The in situ delivery
of cytokines by Lactococcus is warranted for two main strategies: stimulation of the
onset and the maintenance of immune reactions to the co-expressed antigen or as for
interleukin-10, to be used as a therapeutic agent in chronic intestinal inflammation (Steidler,
2002; Steidler et al., 2000).
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2.3.3. Immune responses to Lactococcus vaccines
Immunization studies conducted with using Lactococcus as a vaccine and/or cytokine
delivery vehicle are listed in Table 2. Several routes of immunization have been
investigated (Table 2), including mucosal and parenteral routes, the mucosal route of
delivery being the most commonly used. Antigens delivered by the mucosal route have
been shown to elicit antigen-specific mucosal as well as systemic antibody responses
(Table 2), although both responses have not always been obtained simultaneously (Chatel
et al., 2001; 2003; Grangette et al., 2002; Lee et al., 2001; Mannam et al., 2004; Pontes et
al., 2003). Few studies have also reported a failure to elicit a local antibody response
after a mucosal administration of the antigen (Grangette et al., 2002; Lee et al., 2001).
Several studies have shown that mucosal immunization can lead to antigen specific
immune responses at a distant mucosal site in addition to the induction site (Chatel et al.,
2001; Norton et al., 1997; Robinson et al., 1997; 2004).
The isotypes of IgG antibodies elicited in response to Lactococcus vaccines have
been determined in numerous immunization studies (Table 2). The mucosal route of
immunization with TTFC Lactococcus vaccine strains has been documented to lead to
the predominance of isotypes IgG1 and IgG2a (Robinson et al., 1997; 2004) or to the
predominance of isotypes IgG1 and IgG2b (Grangette et al., 2002; 2004; Norton et al.,
1997), indicating that the antigen-specific T-helper subset responses cannot be predicted
solely on the basis of the used antigen or route of immunization, but vary according to
the used immunization scheme. Intraperitoneal (i.p.) immunizations with Lactococcus
vaccine strains have resulted in the detection of IgG isotypes IgG1 and IgG3 (Gilbert et
al., 2000; Robinson et al., 2004). The route and scheme of immunization thus determine
the IgG isotype profile elicited by Lactococcus vaccines.
The cellular immune responses occurring in the recipient after encountering
Lactococcus expressing a heterologous antigen have thus far been studied by both in
vitro and in vivo assays only in reports by Bermúdez-Humarán et al. (2003c), Robinson
et al. (2004) and Xin et al. (2003). Antigen-specific cellular immune responses have been
detected in spleen and in mesenteric lymph nodes following the mucosal delivery of
Lactococcus vaccine carriers, leading to the secretion of Th1 and Th2 cytokines
(Bermúdez-Humarán et al., 2003c; Robinson et al., 2004). By the i.p. route of vaccination
with lactococci expressing TTFC intracellularly, the cytokine expression profile of the
spleen cells varied depending on the stimulus agent used (Bermúdez-Humarán et al.,
2003c).
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A number of factors have been shown to influence to the immunogenicity of the
antigens delivered by Lactococcus antigen carriers. The form in which the antigen is
associated with the lactococcal cell has been shown to affect its immunogenicity. Studies
by Norton et al. (1996) and Bermúdez-Humarán et al. (2004) have shown that a cell-
surface-displayed form of the antigen is more immunogenic than intracellular or secreted
forms of the antigen. Studies by Bermúdez-Humarán et al. (2004) and Mercenier et al.
(2000) have indicated dose-dependent antigen-specific immune responses, but an increased
dosage of Lactococcus antigen carriers has not always improved the immune responses
obtained (Mannam et al., 2004). The immunogenicity of Lactococcus vaccine carriers is
most likely not dependent upon their viability in vivo, since immunological responses of
the same magnitude have been obtained in immunizations with killed and live Lactococcus
vaccine vehicles by the mucosal route (Grangette et al., 2002; Norton et al., 1997; Robinson
et al., 1997). Chatel et al. (2003) have, however, reported a failure of killed Lactococcus
vaccine carriers, administered by the parenteral route, to elicit antigen-specific immune
responses, although no comparison with corresponding live lactococcal vectors given by
the same route was made in the study.
Several strategies, including the use of adjuvants and the genetic modification of the
Lactococcus vaccine strains, have been exploited for the enhancement of immune
responses elicited by Lactococcus vaccine vectors. Adjuvants used in Lactococcus vaccines
include cholera toxin (Norton et al., 1997), commercial adjuvants (Enouf et al., 2001)
and cytokines (Bermúdez-Humarán et al., 2003c; Steidler et al., 1998a). Cholera toxin,
used as an adjuvant for Lactococcus vaccines delivered by the intranasal (i.n.) route, has
been shown to enhance mucosal but not serum antibody responses to TTFC (Norton et
al., 1997). Cytokines are being tested as adjuvants because of their involvement as immune
response mediators participating in the initiation, maintenance and resolution of both
innate and acquired immune responses (Taylor, 1995). Both simultaneous production of
antigen and cytokine in one Lactococcus strain and the use of separate Lactococcus
strains for the antigen and cytokine production have been tested in immunization studies,
both strategies having shown enhancement of antigen-specific immune responses
compared to immunization without the cytokine (Bermúdez-Humarán et al., 2003c;
Steidler et al., 1998a). The adjuvant effect of cytokine co-expression was lost when the
Lactococcus strains were killed before immunization, suggesting that active secretion of
the cytokines in vivo by recombinant lactococci is required (Steidler et al., 1998). Grangette
et al. (2004) have used alanine racemase mutant strains of lactococci with increased
membrane permeability for the intracellular expression of TTFC, and the superiority of
these mutant strains in eliciting TTFC-specific antibody responses compared with their
wild-type counterparts was demonstrated in mucosal immunizations.
2.3.4. Lactobacillus species as vaccine vectors
The Lactobacillus genus, with over a hundred species recognized at present, is very
heterogeneous, these species possessing differences in their metabolism, distribution in
nature and phenotypic properties such as adhesion capability (Mercenier et al., 2000).
The heterogeneity of the Lactobacillus group is reflected in the number of species currently
studied as possible antigen carriers including L. fermentum, L. plantarum, L. casei, L.
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paracasei, Lactobacillus jensenii and L. johnsonii. The Lactobacillus strains studied as
possible vaccine carriers are commensals of humans or other animals or of dietary origin.
When developing lactobacilli as vaccine carriers, the choice of the appropriate
Lactobacillus antigen carrier strain is of utmost importance. The factors that need to be
considered include the capacity of the Lactobacillus strain to adhere to and colonize the
relevant epithelial surfaces of the host, adjuvant and immunostimulation properties of
the strain, genetic amenability of the strain and the codon usage preferences of the strain.
Lactobacilli have been shown to be capable of stimulating both non-specific host immune
responses, including the enhancement of phagocytic activity of phagocytic cells, and
specific host immune responses, including the enhancement of humoral immune responses
(Gill et al., 2003). The intrinsic adjuvant activities of lactobacilli, leading to the stimulation
of immune responses to the co-administered antigen, are most likely based on the induction
of cytokines by lactobacilli (Seegers, 2002). Considerable differences among diverse
Lactobacillus species and strains have been found in their ability to induce the expression
of anti- and pro-inflammatory cytokines (Morita et al., 2002; Perdigón et al., 2002). The
immune responses elicited by Lactobacillus vaccines can thus be focused in the required
direction by selecting an appropriate Lactobacillus vaccine carrier strain. The adhesion
of lactobacilli to host epithelial surfaces and subsequent colonization is most likely host-
and tissue- or site-specific (Pouwels et al., 1998). If colonization is expected, it is unlikely
for a single Lactobacillus strain to be used as a vaccine carrier in different hosts or to
deliver antigens to different mucosal cavities within the same host. As a result of the
heterogeneity of the Lactobacillus group, gene cloning and expression tools often need
to be optimized for each Lactobacillus strain used, which has been reflected in the choice
of strains studied for vaccine delivery (Wells et al., 1996). When efficient translation of
the antigen is required the codon usage preferences, varying between different
Lactobacillus species (Pouwels and Leunissen, 1994), also need to be considered.
Antigens produced by Lactobacillus vaccine carriers include those of bacterial (Zegers
et al., 1999), viral (Ho et al., 2005) and eukaryotic (Maassen et al., 2003) origin. Antigens
have been produced in lactobacilli intracellularly, extracellularly and surface exposed, of
which the intracellular and surface displayed production seem to be the most widely
studied forms, as can be concluded from strains used for immunization studies (Table 3).
As in Lactococcus, the most widely studied antigen in lactobacilli is also TTFC. The
capacity of many lactobacilli to stimulate the expression of cytokines probably explains
why lactobacilli have not yet been studied as cytokine production hosts.
Review of the Literature
34
Review of the Literature
H
o
st
A
n
ti
g
en
 o
r 
a
n
ti
b
o
d
y
 
fr
a
g
m
en
t/
o
ri
g
in
a
C
el
lu
la
r 
lo
ca
ti
o
n
 
in
 l
a
ct
o
b
a
ci
ll
i 
R
o
u
te
 o
f 
im
m
u
n
iz
a
ti
o
n
 
(a
n
im
a
l)
Im
m
u
n
e 
re
sp
o
n
se
s 
o
b
ta
in
ed
  
[s
tu
d
ie
d
 b
u
t 
n
o
t 
o
b
ta
in
ed
] 
R
ef
er
en
ce
 
L
.
p
la
n
ta
ru
m
 
T
T
F
C
/C
lo
st
ri
d
iu
m
 t
et
a
n
i
In
tr
ac
el
lu
la
r
s.
c.
 (
m
o
u
se
) 
Ig
G
P
av
an
 e
t 
al
.,
 2
0
0
0
 
In
tr
ac
el
lu
la
r
Ig
G
 (
o
ra
l,
 i
.n
.)
, 
Ig
A
 (
i.
n
.)
, 
an
ti
g
en
-
sp
ec
if
ic
 T
-c
el
l 
ac
ti
v
at
io
n
 (
i.
n
.)
 a
n
d
 
an
ti
g
en
-s
p
ec
if
ic
 a
n
ti
b
o
d
y
 s
ec
re
ti
n
g
 c
el
ls
 
(i
.n
.)
L
.
p
la
n
ta
ru
m
T
T
F
C
/C
. 
te
ta
n
i
S
u
rf
ac
e 
d
is
p
la
y
ed
 
i.
g
. 
, 
i.
n
. 
(m
o
u
se
) 
Ig
G
 (
 i
.n
.)
, 
Ig
A
 (
i.
n
.)
 
S
h
aw
 e
t 
al
.,
 2
0
0
0
 
L
.
p
la
n
ta
ru
m
T
T
F
C
/C
. 
te
ta
n
i
In
tr
ac
el
lu
la
r
i.
n
. 
(m
o
u
se
) 
Ig
G
1
, 
Ig
G
2
a,
 I
g
G
2
b
, 
Ig
A
, 
T
T
F
C
 
p
ro
te
ct
io
n
, 
an
ti
g
en
 s
p
ec
if
ic
 T
-c
el
l 
p
ro
li
fe
ra
ti
v
e 
re
sp
o
n
se
 [
Ig
G
3
] 
G
ra
n
g
et
te
 e
t 
al
.,
 2
0
0
1
 
L
.
p
la
n
ta
ru
m
 
T
 c
el
l 
ep
it
o
p
e 
o
f 
D
er
 p
 
1
/h
o
u
se
 d
u
st
 m
it
e 
In
tr
ac
el
lu
la
r
i.
n
. 
(m
o
u
se
) 
In
d
u
ct
io
n
 o
f 
D
er
 p
 1
 –
sp
ec
if
ic
 T
-c
el
ls
 
p
ro
d
u
ci
n
g
 I
F
N
-?
 [
IL
-5
, 
IL
-1
0
]
K
ru
is
se
lb
ri
n
k
 e
t 
al
.,
 
2
0
0
1
L
.
p
la
n
ta
ru
m
T
T
F
C
/C
. 
te
ta
n
i
In
tr
ac
el
lu
la
r
i.
g
. 
(m
o
u
se
) 
Ig
G
1
, 
Ig
G
2
a,
 I
g
G
2
b
, 
p
ro
te
ct
iv
e 
h
u
m
o
ra
l 
re
sp
o
n
se
 [
Ig
A
]
G
ra
n
g
et
te
 e
t 
al
.,
 2
0
0
2
 
In
tr
ac
el
lu
la
r
Ig
G
 (
s.
c.
, 
i.
n
.,
 i
.g
.)
, 
Ig
A
 (
i.
n
.,
 i
.g
.)
 
E
x
tr
ac
el
lu
la
r
Ig
G
 (
s.
c.
, 
i.
n
.,
 i
.g
.)
, 
Ig
A
 (
i.
n
.,
 i
.g
.)
 
L
.
p
la
n
ta
ru
m
 
T
T
F
C
/C
. 
te
ta
n
i
S
u
rf
ac
e 
d
is
p
la
y
ed
 
s.
c.
, 
i.
n
. 
o
r 
i.
g
. 
(m
o
u
se
) 
Ig
G
 (
s.
c.
, 
i.
n
.,
 i
.g
.)
, 
Ig
A
 (
i.
n
.)
 
R
ev
en
ea
u
 e
t 
al
.,
 2
0
0
2
 
L
.
p
la
n
ta
ru
m
  
L
. 
ca
se
i 
H
ac
k
et
t 
ep
it
o
p
e/
 
in
fl
u
en
za
 v
ir
u
s 
In
tr
ac
el
lu
la
r
s.
c.
 p
ri
m
in
g
 
fo
ll
o
w
ed
 b
y
 o
ra
l 
im
m
u
n
iz
at
io
n
 
(m
o
u
se
) 
B
o
o
st
er
 e
ff
ec
t 
in
 s
er
u
m
 
P
o
u
w
el
s 
et
 a
l.
, 
1
9
9
6
 
i.
v
. 
(m
o
u
se
) 
Ig
G
L
.
p
la
n
ta
ru
m
T
T
F
C
/C
. 
te
ta
n
i
In
tr
ac
el
lu
la
r
i.
g
. 
(m
o
u
se
) 
Ig
G
1
, 
Ig
G
2
a,
 I
g
G
2
b
, 
p
ro
te
ct
iv
e 
h
u
m
o
ra
l 
re
sp
o
n
se
, 
lo
ca
l 
Ig
A
 [
Ig
G
3
, 
se
ru
m
 I
g
A
] 
G
ra
n
g
et
te
 e
t 
al
.,
 2
0
0
4
 
L
. 
ca
se
i 
T
T
F
C
/C
. 
te
ta
n
i
S
u
rf
ac
e 
d
is
p
la
y
ed
 
s.
c.
 (
m
o
u
se
) 
Ig
G
M
aa
ss
en
 e
t 
al
.,
 1
9
9
9
 
L
. 
ca
se
i 
P
A
/B
a
ci
ll
u
s 
a
n
th
ra
ci
s
In
tr
ac
el
lu
la
r
O
ra
l,
 i
.n
, 
i.
p
. 
(m
o
u
se
) 
Ig
G
 (
i.
p
.)
  
[P
A
 s
p
ec
if
ic
 a
n
ti
b
o
d
y
 r
es
p
o
n
se
 
b
y
 o
ra
l 
o
r 
i.
n
. 
im
m
u
n
iz
at
io
n
] 
Z
eg
er
s 
et
 a
l.
, 
1
9
9
9
 
In
tr
ac
el
lu
la
r
Ig
G
 (
 i
.n
.)
 
L
. 
ca
se
i
T
T
F
C
/C
. 
te
ta
n
i
S
u
rf
ac
e 
d
is
p
la
y
ed
 
i.
g
.,
 i
.n
. 
(m
o
u
se
) 
n
.d
.*
 [
Ig
G
] 
S
h
aw
 e
t 
al
.,
 2
0
0
0
 
Ta
bl
e 
3.
 Im
m
un
iz
at
io
n 
st
ud
ie
s w
ith
 L
ac
to
ba
ci
llu
s s
pp
. a
s a
n 
an
tig
en
 o
r a
nt
ib
od
y 
fr
ag
m
en
t d
el
iv
er
y 
ve
hi
cl
e.
35
Review of the Literature
a  d
er
 P
, a
n 
al
le
rg
en
 o
f h
ou
se
 d
us
t m
ite
; h
C
G
β, 
β s
ub
un
it 
of
 h
um
an
 c
ho
rio
ni
c 
go
na
do
tro
pi
n;
 g
pM
B
P,
 g
ui
ne
a 
pi
g 
m
ye
lin
 b
as
ic
 p
ro
te
in
; P
A
,
pr
ot
ec
tiv
e 
an
tig
en
; P
rtB
; p
ro
te
in
as
e 
B
; s
cF
v,
 si
ng
le
 c
ha
in
 fr
ag
m
en
t v
ar
ia
bl
e;
 T
TF
C
, t
et
an
us
 to
xi
n 
fr
ag
m
en
t C
; T
Tm
im
, t
et
an
us
 to
xi
n 
m
im
ot
op
e;
TG
EV
, t
ra
ns
m
is
si
bl
e 
ga
st
ro
en
te
rit
is
 c
or
on
av
iru
s.
* 
n.
d.
, n
ot
 d
et
ec
te
d
L
. 
ca
se
i 
G
u
y
´s
 1
3
 s
cF
v
/m
o
u
se
 
m
o
n
o
cl
o
n
al
 I
g
G
1
 
S
u
rf
ac
e
ex
p
re
ss
io
n
O
ra
l 
(r
at
) 
R
ed
u
ct
io
n
 i
n
 S
tr
ep
to
co
cc
u
s 
m
u
ta
n
s
b
ac
te
ri
al
 c
o
u
n
ts
 a
n
d
 d
en
ta
l 
ca
ri
es
 
K
rü
g
er
 e
t 
al
.,
 2
0
0
2
 
g
p
M
B
P
/g
u
in
ea
 p
ig
 
E
x
tr
ac
el
lu
la
r 
i.
n
.,
 i
.g
. 
(r
at
)
In
d
u
ct
io
n
 o
f 
in
tr
an
as
al
 t
o
le
ra
n
ce
 [
g
p
M
B
P
 
sp
ec
if
ic
 a
n
ti
b
o
d
y
 r
es
p
o
n
se
 b
y
 i
.g
. 
o
r 
i.
n
. 
im
m
u
n
iz
at
io
n
, 
o
ra
l 
to
le
ra
n
ce
 i
n
d
u
ct
io
n
] 
E
x
tr
ac
el
lu
la
r 
i.
n
.,
 i
.g
. 
(r
at
) 
In
d
u
ct
io
n
 o
f 
in
tr
an
as
al
 a
n
d
 o
ra
l 
to
le
ra
n
ce
 
[g
p
M
B
P
 s
p
ec
if
ic
 a
n
ti
b
o
d
y
 r
es
p
o
n
se
 b
y
 
i.
g
. 
o
r 
i.
n
. 
im
m
u
n
iz
at
io
n
] 
L
. 
ca
se
i 
M
B
P
7
2
-8
5
/g
u
in
ea
 p
ig
 
In
tr
ac
el
lu
la
r
i.
g
. 
(r
at
) 
In
d
u
ct
io
n
 o
f 
o
ra
l 
to
le
ra
n
ce
 [
g
p
M
B
P
 
sp
ec
if
ic
 a
n
ti
b
o
d
y
 r
es
p
o
n
se
 b
y
 i
.g
. 
o
r 
i.
n
. 
im
m
u
n
iz
at
io
n
] 
M
aa
ss
en
 e
t 
al
.,
 2
0
0
3
 
L
. 
ca
se
i 
h
C
G
?/
h
u
m
an
 
E
x
tr
ac
el
lu
la
r
i.
v
. 
(m
o
u
se
) 
Ig
A
, 
an
ti
g
en
-s
p
ec
if
ic
 l
y
m
p
h
o
cy
te
s,
 I
F
N
-?
an
d
 I
L
-4
 p
ro
d
u
ct
io
n
  
Y
ao
 e
t 
al
.,
 2
0
0
4
 
L
. 
ca
se
i 
F
ra
g
m
en
t 
o
f 
sp
ik
e 
g
ly
co
p
ro
te
in
 S
/T
G
E
V
 
E
x
tr
ac
el
lu
la
r
i.
g
. 
(m
o
u
se
) 
Ig
A
, 
Ig
G
, 
in
d
u
ct
io
n
 o
f 
an
ti
b
o
d
ie
s 
w
it
h
 
n
eu
tr
al
iz
in
g
 e
ff
ec
ts
 o
n
 T
G
E
V
 i
n
fe
ct
io
n
 
H
o
 e
t 
al
.,
 2
0
0
5
 
L
.
jo
h
n
so
n
ii
 
T
T
m
im
-P
rt
B
/C
.t
et
a
n
i,
L
a
ct
o
b
a
ci
ll
u
s 
d
el
b
ru
ec
ki
i
su
b
sp
.
b
u
lg
a
ri
cu
s
S
u
rf
ac
e 
d
is
p
la
y
ed
 
i.
g
. 
(m
o
u
se
) 
P
rt
B
 s
p
ec
if
ic
 I
g
G
 a
n
d
 I
g
A
 
S
ch
ep
p
le
r 
et
 a
l.
, 
2
0
0
2
 
A
n
ti
-i
d
io
ty
p
ic
 
sc
F
v
/h
u
m
an
A
n
ti
-?
-I
d
sc
F
v
2
 I
g
G
 (
s.
c.
, 
i.
n
.)
, 
an
ti
-I
g
E
 
Ig
G
 (
s.
c.
, 
i.
n
.)
 
L
.
jo
h
n
so
n
ii
 
Ig
E
 m
im
o
to
p
e/
h
u
m
an
 
S
u
rf
ac
e 
d
is
p
la
y
ed
 
s.
c.
, 
i.
n
. 
(m
o
u
se
) 
A
n
ti
-?
-I
d
sc
F
v
2
 I
g
G
 (
i.
n
.)
, 
an
ti
-I
g
E
 I
g
G
 
(s
.c
.,
 i
.n
.)
 [
A
n
ti
-?
-I
d
sc
F
v
2
 I
g
G
 (
s.
c.
)]
 
S
ch
ep
p
le
r 
et
 a
l.
, 
2
0
0
5
 
36
2.3.5. Immune responses to Lactobacillus vaccines
Immunization studies conducted with using Lactobacillus spp. as an antigen or antibody
fragment delivery vehicle are listed in Table 3. The most commonly used route of
immunization has been the intragastric (i.g.) or oral delivery of Lactobacillus vaccines,
and other routes of mucosal delivery, including the i.n. or intravaginal (i.v.) routes, and
parenteral delivery, have also additionally been tested. When the mucosal route of antigen
delivery has been used, antigen-specific mucosal as well as systemic antibody responses
have been obtained, although sometimes either of the responses has been lacking (Table
3). The IgG isotypic profiles obtained after mucosal delivery of the Lactobacillus vaccines
suggest the activation of both Th1 and Th2 T helper cell subsets (Grangette et al., 2001;
2002; 2004). Humoral mucosal responses at distant mucosal sites with Lactobacillus
vaccine carriers have not been studied, except by Shaw et al. (2000), who by nasal priming
followed by an oral boost detected no IgA responses in bronchoalveolar lavage fluids of
mice immunized by L. plantarum vaccine carriers. With the parenteral route of antigen
delivery an antigen-specific IgG response has always been obtained (Table 3).
In addition to humoral responses, other types of responses to Lactobacillus vaccine
vectors have also been detected. The cellular immune responses occurring in the recipient
after the delivery of Lactobacillus vaccine vectors have been studied in several reports.
Immunization with Lactobacillus vaccines has been shown to lead to antigen-specific T-
cell proliferative responses (Grangette et al., 2001; Kruisselbrink et al. 2001; Shaw et al.,
2000) or lymphocyte proliferative responses (Yao et al., 2004). Other cellular responses
observed include the detection of antigen-specific antibody secreting cells (Shaw et al.,
2000) and the production of cytokines by the induced T cells (Kruisselbrink et al., 2001).
The efficacy of Lactobacillus as a mucosal delivery vehicle in therapeutics has been
demonstrated by Krüger et al. (2002) and Maassen et al. (2003). Lactobacilli surface
expressing a single-chain Fv antibody fragment, which recognizes the adhesion molecule
of Streptococcus mutans, was shown to reduce the number of S. mutans cells and caries
scores in a rat model of dental caries development (Krüger et al., 2002). A reduction in
experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis,
was found when lactobacilli expressing guinea pig myelin antigens were used in mucosal
immunization (Maassen et al., 2003). A method applicable for the tracing of Lactobacillus
antigen carriers after administration and for analyzing host immune cell-Lactobacillus
interactions was described by Geoffroy et al. (2000), who by using green fluorescent
protein carrying lactobacilli showed their active phagocytosis by macrophages in vitro
and also after administration ex vivo.
Factors shown to influence to the immunogenicity of the antigens delivered by
Lactobacillus include the cellular location of the antigen, production level of the antigen
and the viability of the carrier strain. When effects of the cellular location of the antigen
in Lactobacillus vaccines have been studied, contradictory results have been reported.
Reveneau et al. (2002) obtained the highest humoral responses to TTFC delivered
mucosally with an intracellular form of TTFC, but the cell-surface associated and secreted
forms of TTFC were found to be more immunogenic than the intracellular form of TTFC.
In a study by Shaw et al. (2000), the intracellularly produced TTFC was, however,
concluded to be more effective in producing antigen-specific humoral responses than the
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surface-expressed form of TTFC delivered mucosally. When the parenteral route of
delivery was used, the cellular location of TTFC had no effect on the immune responses
obtained, since they were of similar levels with all of the constructs (Reveneau et al.,
2000). Several studies (Grangette et al., 2001; 2002; Pavan et al., 2000; Reveneau et al.,
2002) have shown that the absolute level of the antigen produced by Lactobacillus vaccine
strains is a key factor in determining the level of immune responses obtained, and that
the addition of the antigen dose leads to an enhancement of the immune response. The
effect of the viability of Lactobacillus vaccine strains to the immune responses obtained
has been studied with strains expressing TTFC intracellularly (Grangette et al., 2001;
2002). The results from these studies have shown that the antibody responses elicited by
live and inactivated vectors are of similar levels, although the level of protective responses
against TTFC was found to be higher with live carriers.
Lactococcus and Lactobacillus antigen carriers have been compared in their ability
to elicit immune responses to the co-expressed antigen in studies by Grangette et al.
(2002; 2004). Similar levels of intracellular antigen production in lactococci and
lactobacilli were found to lead to significantly lower immune responses with Lactococcus
vaccine strains compared to L. plantarum vaccine strains, determined by humoral
responses and by the protective capacity of anti-TTFC serum antibodies in a neutralization
assay (Grangette et al., 2001; 2004). The isotypic profiles of anti-TTFC antibodies were
similar in both Lactococcus and Lactobacillus antigen carriers (Grangette et al., 2001;
2004). When alanine racemase mutant strains of Lactobacillus and Lactococcus antigen
carrier strains were used, the immunogenicity of the Lactococcus vaccines delivered by
the i.g. route was enhanced to a similar level with the Lactobacillus vaccines, but by the
i.v. route of delivery the immunogenicity of Lactococcus mutant vaccine strain remained
at a lower level than obtained with the equivalent Lactobacillus strain (Grangette et al.,
2004).
2.3.6 Streptococcus gordonii as a vaccine vector
S. gordonii is a nonpathogenic bacterium belonging to the normal microbiota of the
human oral cavity (Lee, 2003) and has been widely studied as a putative vaccine vector.
The colonization potential of S. gordonii vaccine vector strains should be excellent, since
in humans S. gordonii is one of the first organisms to colonize the oral cavity (Lee,
2003). Streptococcus gordonii has been shown to stably colonize the oral (Lee et al.,
2002) and vaginal cavities (Medaglini et al., 1997) of mice and the vaginal mucosa of
rats (Beninati et al., 2000), while persisting only transiently in the vaginal cavity of
monkeys (Di Fabio et al., 1998). The murine intestinal mucosa has also been shown to be
colonized by S. gordonii (Ricci et al., 2000) for a few weeks, whereas the colonization of
the murine oral and vaginal mucosa can continue for up to twelve (Sharma et al., 2001)
or six (Medaglini et al., 1997) weeks, respectively. No differences in colonization capacities
have been found between recombinant and wild-type S. gordonii in the vaginal or oral
mucosa of mice (Medaglini et al., 1995; 1997; Oggioni et al., 1995). The colonization
properties of S. gordonii allow a long-lasting exposure of the host to the antigens delivered
by the S. gordonii vaccine carriers, since the antigen is constantly expressed in vivo
(Medaglini et al., 1998). Due to its persistant nature, a single oral inoculation with a S.
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gordonii vaccine vector could in principle provide life-long immunity to a desired antigen
(Lee, 2003).
A wide variety of antigens with a bacterial (Sharma et al., 1996), viral (Di Fabio et
al., 1998) or eukaryotic (Ricci et al., 2003) origin have been produced by S. gordonii.
Research has focused on studying the possible use of S. gordonii vaccine carriers for the
prevention of sexually-transmitted diseases and several antigens of sexually-transmitted
pathogens have therefore been expressed by recombinant S. gordonii (Table 4).
The majority of antigens expressed by S. gordonii have been surface displayed, the
other expression site under study being the extracellular location (Table 4). The most
widely studied system for the heterologous surface expression of antigens in S. gordonii
is based on a translational gene fusion encoding the signal sequence and anchor of the S.
pyogenes M6-protein with the heterologous protein (Pozzi et al., 1992). Transformation
of the recombinant vectors to recipient strains of S. gordonii leads to the chromosomal
integration of the gene fusion downstream of a strong resident promoter (Oggioni et al.,
1996, Pozzi et al., 1992). Extracellular production of the heterologous antigens with the
aforementioned system can be achieved by inserting a translational stop codon sequence
before the anchor sequence of M6 (Sharma et al., 1997). A factor that aids in the
construction of S. gordonii recombinant strains is the natural capability of S. gordonii for
genetic transformation (Pozzi et al., 1990).
Some potential problems related to the safety of S. gordonii as vaccine carriers exist,
which need to be evaluated if these vectors are intended to be used in humans. The M6
protein, used as the fusion partner in most of the expression constructs, is considered to
be a virulence determinant of S. pyogenes (Mercenier et al., 2000). S. gordonii has also
been associated with some diseases, such as infective endocarditis in humans (Douglas
et al., 1993) and dental caries in rats (Tanzer et al., 2001). However, the results of a
recent clinical study with human volunteers exposed to a S. gordonii strain not bearing
any vaccine antigens further encourage the development of a S. gordonii mucosal vaccine
vector (Kotloff et al., 2005). In this study the S. gordonii strain was given by combined
nasal and oral inoculation and was found to be well tolerated, highly colonizing and
removable either spontaneously or by antibiotic treatment.
2.3.7. Immune responses to Streptococcus vaccines
S. gordonii was the first recombinant commensal bacterium used as a live vaccine vector
(Potzi et al., 1992). Immunization studies performed with S. gordonii antigen and/or
cytokine carriers are listed in Table 4. Most often the mucosal route of delivery has been
used, although the parenteral route of delivery has also been widely studied in the context
of S. gordonii vaccines. In a few studies two different mucosal routes have been
simultaneously used (Bolken et al., 2002; Lee et al., 2002; Oggioni et al., 1995). A local
IgA response has almost always been obtained after the mucosal immunization with S.
gordonii antigen carriers, and likewise after the parenteral route of delivery a systemic
humoral response has almost always been obtained (Table 4). In most of the studies
conducted with S. gordonii vaccines, the mucosal route of delivery has also elicited antigen-
specific systemic humoral responses (Table 4). When the parenteral route of delivery has
been used, the predominant or only IgG isotype observed has been the IgG1, suggesting
39
Review of the Literature
a Th2 type of response to the antigen delivered by this route (Medaglini et al., 2001;
Oggioni et al., 1999; Ricci et al., 2000). The isotypic profiles obtained after the mucosal
delivery of S. gordonii antigen carriers have, however, suggested the recruitment of Th1
responses (Oggioni et al., 1999) or the activation of both Th1 and Th2 T helper cell
subsets (Medaglini et al., 2001; Ricci et al., 2000). The route of antigen delivery thus
seems to have an important role in determining the nature of the immune responses
elicited by S. gordonii antigen carriers.
Dendritic cells are the most likely mediators of immune responses to S. gordonii
antigen carriers (Corinti et al., 2000). Human and mouse dendritic cells have been shown
to internalize both wild-type S. gordonii cells and S. gordonii cells expressing a
heterologous antigen by phagocytosis, leading to the maturation and activation of dendritic
cells (Corinti et al., 1999; Rescigno et al., 1998). The subsequent antigen presentation to
CD4+ T lymphocytes has been demonstrated by in vitro analyses (Corinti et al., 1999;
2000). Recombinant antigens expressed on the S. gordonii cell surface were shown to be
presented to T lymphocytes with the major histocompatibility complex class I molecules
106 times more efficiently than the same antigen in a soluble form (Rescigno et al., 1998).
The activation of T-cells after encountering S. gordonii antigen carriers in vivo has been
demonstrated by Di Fabio et al. (1998), who obtained a T cell proliferative response after
the i.v. immunization of monkeys.
A novel approach contrasting with the active immunization with S. gordonii antigen
carriers aims at the selective delivery of therapeutic agents, such as antibody fragments,
for the prevention and therapy of mucosal diseases. Experimental vaginitis, caused by
Candida albicans, has been successfully treated with S. gordonii secreting or displaying
a microbicidal single-chain antibody, resulting in the enhancement of the infection
clearance by both of the recombinants (Beninati et al., 2000). Another example of the
successful delivery of a therapeutic agent by S. gordonii, leading to the reduction of
disease severity in a mouse model of human ulcerative colitis, has been reported by Ricci
et al. (2003).
Factors shown to influence to the immunogenic properties of S. gordonii therapeutic
protein/antigen carriers include the cellular location of the heterologous protein and the
viability of the S. gordonii carrier strains. Beninati et al. (2000) have shown that a secreted
form of a therapeutic antibody fragment led to a more pronounced therapeutic effect than
the surface-displayed form of the same molecule. Due to the fact that all S. gordonii
antigen carriers used in immunizations have had a surface-displayed form of the antigen
(Table 4), the effects of different cellular locations of the antigen on the immune responses
elicited have not been compared. The colonization of S. gordonii antigen carriers seems
to be a prerequisite for the induction of mucosal immune responses. When a mucosal
route of delivery has been used, antigen-specific mucosal IgA responses have not been
obtained by using killed S. gordonii antigen carriers (Medaglini et al., 1995; Oggioni et
al., 1995) and the induction of systemic IgG responses have only been described in one
study (Medaglini et al., 1997). When given parenterally, killed S. gordonii vaccine carriers
have been reported to induce a systemic humoral response (Lee et al., 1999; 2004).
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To modulate the magnitude and direction of immune responses elicited by S. gordonii
antigen carriers, the use of different adjuvants including Freund’s incomplete (Lee et al.,
1999) and Freund’s complete adjuvant (Lee et al., 2004; Pozzi et al., 1992), B monomer
of E. coli heat-labile toxin (LTB) (Maggi et al., 2002), cholera toxin subunit B (Lee et al.,
2004), an immunostimulating CpG oligonucleotide (Lee et al., 2004), and cytokines (Byrd
et al., 2002) have thus far been tested. The co-expression of LTB simultaneously at the
cell surface with the V3 domain of human immunodeficiency virus (HIV)-1 gp 120 resulted
in a four-fold higher V3-specific IgG titer compared to the titers induced by S. gordonii
expressing only the V3 domain alone or titers induced by a mixture of strains expressing
LTB and V3 separately (Maggi et al., 2002). The extracellular expression of two different
cytokines together with a surface-displayed form of antigen in S. gordonii has been
reported by Byrd et al. (2002), who demonstrated several immunomodulatory effects,
including the up or down regulation of several genes associated with the immune response,
due to the cytokine and antigen co-expression.
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3. AIMS OF THE STUDY
Encouraging results from immunization studies with LAB vaccine vectors further support
the establishment of new and even more efficient antigen display systems. This study
was aimed at the development of LAB vaccine vectors and adjuvant cytokine production
systems. As a potential antigen display vehicle, the S-layer protein SlpA of L. brevis
ATCC 8287 was chosen for this study. In addition, the S-layer of L. brevis ATCC 14869
was chosen for basic characterization to aid structure-function analysis of L. brevis S-
layers and to clarify the binding characteristics of these structures. For further
characterization of the S-layer protein binding properties, the receptor binding domain
of the L. brevis SlpA was also studied using a non-adhesive heterologous host.
The specific aims of the present work were the following:
1. To characterize the genes encoding the S-layer protein of L. brevis ATCC 14869 and
study their expression in different growth conditions.
2. To investigate the use of S-layer protein SlpA of L. brevis ATCC 8287 as a carrier of
foreign epitopes.
3. To examine the expression of the SlpA receptor-binding region of L. brevis ATCC
8287 in nonadhesive lactococci.
4. To create an expression system for porcine IL-2 in Lactococcus lactis and study the
specific biological activity of the expressed IL-2.
Aims of the Study
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4. MATERIALS AND METHODS
4.1. Bacterial strains, plasmids, cell lines, and growth conditions
The microbial strains, plasmids, cell lines, antibiotics and growth conditions used in this
study are described in publications I-IV.
4.2. DNA methods and transformation
Routine molecular biology techniques were applied (Sambrook and Russell, 2001). DNA
restriction enzymes and modification enzymes were used as recommended by the the
manufacturers (Promega, Madison, Wis.; New England Biolabs Inc., Beverly, Mass.).
Chromosomal DNA was isolated from L. brevis essentially as described by Vidgrén et al.
(1992). Plasmid isolation from E. coli was performed with Wizard Minipreps (Promega)
and from L. lactis and L. brevis with the QIAfilter Plasmid Midi Kit (Qiagen GmbH,
Hilden, Germany) and using increased lysozyme concentration (8 mg/ml). L. brevis was
transformed essentially as described by Bhowmik and Steele (1993). Transformation of
L. lactis and E.coli was performed by the methods of Holo and Nes (1989) and Sambrook
and Russell (2001), respectively. The polymerase chain reaction (PCR) was carried out
using the manufacturer’s recommended reaction conditions (Finnzymes). Real-time
quantitative PCR was performed with an iCycler (Bio-Rad Laboratories) in reaction
conditions presented in Study I. The Vectorette system (Sigma Genosys Ltd.) was used
for amplifying and sequencing the L. brevis ATCC 14869 slp gene regions. DNA
sequencing and sequence analyses performed are described in detail in Study I. Southern
blotting was carried out by the method of Southern (1975) and hybridizations were
performed as described in Studies I and II.
4.3. RNA methods and RT-PCR
Total RNA (ribonucleic acid) was isolated with the Rneasy minikit (Qiagen) from L.
brevis cells lyzed by a cell homogenizator with glass beads as described in Study I. From
stimulated PBMC total RNA was extracted as described in Study IV. RNA gel
electrophoresis and Northern blotting was performed with the method of Hames and
Higgins (1985). Oligonucleotide probes were labelled with digoxigenin-dUTP by using
the DIG-High Prime kit (Boehringer Mannheim). Detection of the probe-specific hybrids
was carried out by using the DIG luminescence kit (Boehringer Mannheim). Primer
extension reactions for the 5´end determination of transcripts and the reverse transcriptase
reactions were performed as described in Study I.
RT-PCR of RNA samples was done either by using the iScript cDNA synthesis kit
(Bio-Rad Laboratories) or the RobusT RT-PCR-kit (Finnzymes) as recommended by the
manufacturers.
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4.4. Protein and enzyme assays
Sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gel electrophoresis and
immunoblot analyses were carried out as described in Studies I-IV. Intracellular
aminopeptidase activities were determined as described in Study I. Surface-exposed
epitopes or polypeptides were detected by whole-cell enzyme-linked immunosorbent
assay (ELISA) as outlined in Studies II-III, respectively. The N-terminal sequencing of
intact proteins and tryptic peptides was performed with the method of Kalkkinen and
Tilgmann (1988). The molecular mass analyses were carried out as described in Studies
I-II. His-tagged fusion proteins were purified by using a HisTrap HP affinity
chromatography column as recommended by the manufacturer (Amersham Biosciences).
The expression and purification of His-tagged fusion proteins is described in more detail
in Study IV.
4.5. Immunofluorescence
The surface accessibility of epitopes or polypeptides on the bacterial cell surface was
investigated with immunofluorescense assays as described in Studies II-III.
4.6. Bacterial adhesion assays
Bacterial adhesion to Intestine 407 monolayer and human plasma fibronectin was
determined as described in Study III. The statistical methods used in evaluating the results
are described in Study III.
4.7. Electron microscopy
Transmission electron microscopy analyses, carried out as described in Studies I-II, were
used in analyzing the surface structure of bacterial cells.
4.8. Isolation of peripheral blood mononuclear cells and stimulation
Isolation of peripheral blood mononuclear cells (PBMC) from the whole blood of a large
white pig, collected into heparinized tubes, was performed as described in Study IV. For
stimulation of the PBMC, phytohemagglutinin was used as described in Study IV.
4.9. Proliferation assays with the cell line CTLL-2
The biological activity of porcine rIL-2 proteins was examined by using the CellTiter 96
AQueous One Solution Cell Proliferation Assay as recommended by the manufacturer
(Promega) and is described in more detail in Study IV.
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5. RESULTS AND DISCUSSION
5.1. Characterization of the genes encoding the S-layer protein of L. brevis ATCC
14869 (I)
L. brevis strains ATCC 8287 and ATCC 14869 show differences in their ability to bind
porcine epithelial cells (M. Jakava-Viljanen and A. Palva, unpublished results). To resolve
the basis of these differences, the S-layer protein gene content and the slp gene expression
in ATCC 14869 were characterized in detail in this study.
5.1.2. The S-layer protein profile
 During the course of the study, L. brevis ATCC 14869 cells were observed to form two
colony types, smooth (S) and rough (R), on MRS plates when growing under aerobic
conditions for longer periods, whereas under anaerobic conditions only S-type colonies
were formed. This phenomenon has not earlier been described for this L. brevis neotype
strain. Identical 16S ribosomal DNA (rDNA) sequences with L. brevis identity from the
cells of both colony types excluded the possibility of strain contamination. Two putative
S-layer protein bands of 50 and 43 kDa were detected by whole-cell SDS-PAGE analyses
from R-colony type cells propagated on MRS plates and cells grown under aeration in
MRS broth. The 50 kDa band was predominant in cells of the S-colony type and in cells
grown anaerobically in MRS broth. Electron microscopy (EM) analysis revealed the
presence of only a single S-layer with an oblique structure on top of the peptidoglycan
layer on the cells of both colony types. Thus, the EM data do not explain the difference
in the colony morphology but suggest that the S-layer structures are not directly involved.
5.1.3. Cloning and sequence analysis of the slp genes
Degenerate sequencing primers were designed according the N-terminal amino acid
sequences from the purified 50- and 43-kDa S-layer proteins and their tryptic peptides
and the PCR products obtained were used as probes in Southern hybridizations. Based
on the blotting data obtained, HindIII-cut chromosomal DNA was ligated with the HindIII
Vectorette units and the amplifying and sequencing of the slp gene regions were performed
with the Vectorette system.
The amino acid sequence predicted from the orf encoding the 50-kDa S-layer protein
included the N-terminal and internal amino acid sequences determined from this protein.
This orf was designated slpB and was found to encode a polypeptide of 483 aa with a
signal sequence of 30 aa. The molecular weight of the mature SlpB (48 kDa) was found
to be in good agreement with the molecular mass of the 50-kDa protein estimated by
SDS-PAGE. Sequence analysis of the slpB revealed the presence of two putative promoter
regions, a possible RBS and a putative rho-independent type transcription terminator
sequence.
Downstream of the slpB sequence an orf designated slpC with a capacity to encode
a mature protein of 46 kDa was found. Sequence analysis revealed the presence of two
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putative -10 regions for a promoter and a possible RBS, but the gene was not followed by
transcription terminator-like sequences.
Because the predicted DNA sequence and coding capacity of the slpC did not
correspond to the N-terminal sequence and size of the 43-kDa protein S-layer protein
from R-colony type cells, new primers were designed for the isolation of the third gene,
slpD, from the Vectorette library. The orf of slpD gene was found to encode a polypeptide
of 413 aa with a signal sequence of 30 aa. The molecular weight of the mature SlpD (42
kDa) was found to be in good agreement with the molecular mass of the 43-kDa protein
estimated by SDS-PAGE. Two putative -10 regions for a promoter and a possible RBS
were identified from the upstream region of slpD and downstream of the stop codon a
putative rho-independent type transcription terminator sequence could be recognized.
Southern blotting and PCR analysis revealed that the slpD gene is not closely linked to
the slpB-slpC gene region.
  The genetic organization of the three GRL62 slp genes is distinct from that described
so far for other lactobacilli. In L. acidophilus ATCC 4356, the two S-layer protein genes,
slpA and slpB, are in opposite orientation to each other and interspaced with a 3 kb DNA-
region (Boot et al., 1996c). The putative S-layer protein genes apf1 and apf2 of L. gasseri
and L. johnsonii are also separated by a short intergenic DNA-region, but these genes are
in parallel orientation (Ventura et al., 2002). The spacing and orientation of the L. crispatus
S-layer protein genes, cbsA and cbsB, have not yet been deduced (Sillanpää et al., 2000).
From L. brevis ATCC 8287, we have been able to find only one S-layer protein gene,
slpA (Vidgrén et al., 1992; Palva et al., unpublished results). The current data on the
genetic organization of the Lactobacillus S-layer protein genes thus suggest that they are
generally located in a rather close proximity to each other.
The S-layer proteins of L. brevis ATCC 14869 were chacterized in this study in
order to find putative conservative regions with the SlpA protein of L. brevis ATCC
8287. These conservative regions, implicative of regions with similar structural functions,
could have been utilized, for example, in the further optimization of the ATCC 8287 S-
layer protein antigen display system. Homology comparisons of the L. brevis Slp proteins
revealed that the intraspecies identity was mainly restricted to the N-terminal regions of
these proteins, whereas the C-terminal regions were rather divergent. By pairwise protein
sequence alignments computed to the L. brevis Slp proteins a few middle and C-terminal
regions with considerable sequence similarity have, however, been found between the
SlpB and SlpD proteins (Åvall-Jääskeläinen and Palva, 2005). The amino acid sequence
identities of the L. brevis ATCC 14869 Slp proteins to the SlpA protein of L. brevis ATCC
8287 were lower than expected and negligible compared to other S-layer proteins of the
Lactobacillus species studied. Secondary structure predictions computed for the L. brevis
Slp proteins have revealed these proteins to be quite dissimilar when compared to each
other and also to other S-layer proteins of lactobacilli (Åvall-Jääskeläinen and Palva,
2005). Except for the α-helices located at the signal sequences of L. brevis Slp proteins,
the locations of the other observed secondary structures (extended strands and random
coils) in the L. brevis Slp proteins have not been found to be directly comparable to each
other (Åvall-Jääskeläinen and Palva., 2005). Due to the dissimilarity between the S-
layer proteins of the two studied L. brevis strains and also due to the dissimilarity between
the ATCC 14869 Slp and other lactobacillar S-layer proteins, the location of the putative
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receptor-binding domain and the cell wall binding domain of the ATCC 14869 Slp protein/
s cannot be directly determined. On the other hand, sequence alignments between the S-
layer proteins of L. crispatus and L. acidophilus and L. helveticus have shown that the C-
terminal sequences between the S-layer proteins of these lactobacilli are highly similar
(Åvall-Jääskeläinen and Palva., 2005) and contain a putative carbohydrate-binding
consensus sequence, suggested to be involved in cell wall binding (Smit et al., 2001).
For the S-layer proteins of L. brevis ATCC 14869 the adhesin function and location of
the adhesion domain needs to be experimentally confirmed.
5.1.4. Expression studies on the slp genes
The expression of the slp genes of L. brevis ATCC 14869 was studied as a function of
growth. Northern blot analysis confirmed the monocistronic nature of the slpB and slpD
transcripts. With primer extension analysis, a transcription start site of the slpD gene
could also be localized. Under aerated growth conditions, both slpB and slpD were found
to be expressed, whereas under anaerobic growth conditions only expression of slpB was
detected. Under the growth conditions tested, slpC was found to be a silent gene. L.
acidophilus and L. crispatus have also been found to have silent S-layer protein genes
(Boot and Pouwels, 1996; Sillanpää et al., 2000).
For studying a possible chromosomal rearrangement involved in the activation of
the slpD gene expression, real-time quantitative PCR was performed with primers spanning
the slpD promoter region and with chromosomal DNA from ATCC 14869 cells grown
under aerated or anaerobic conditions. The results indicated that chromosomal
rearrangements are not likely to be involved in the regulation of the L. brevis slpD gene
expression. Regulation of S-layer gene expression by DNA arrangements have been
reported to occur in one Lactobacillus species, L. acidophilus (Boot et al., 1996), but the
conditions that would induce this change have not been established.
Expression studies with a PepI reporter protein under the control of the slpD promoter
showed that under aerated conditions the specific PepI activities were growth stage
dependent. Under anaerobic conditions no similar response was observed and the specific
PepI activities remained low.
The results of Northern analyses, expression of a PepI reporter protein under the
control of the slpD promoter and quantitative real-time PCR analysis of slpD expression
under aerated and anaerobic conditions obtained in the study indicated that the variation
in S-layer protein content in GRL62 occurs at the transcriptional level rather than with
DNA rearrangements. When SlpD is produced, the amount of SlpB is lowered and the
level of slpB transcripts is also somewhat decreased. However, there appears to be no
marked repression of slpB transcription, although it might be partly masked by the long
half-life of slpB transcripts. Thus, this suggests that the variation in the S-layer protein
content takes place by a unique mechanism involving activation of slpD transcription in
the exponential growth phase by a soluble factor as a result of an environmental change
in L. brevis ATCC 14869. How this response is triggered, and what all the participating
components are remains to be elucidated. It is also unclear whether the variation in the
colony forms and slp gene expression are connected by the same regulon or whether they
are independent events. Furthermore, it cannot yet be predicted whether the change in
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redox potential or amount of dissolved oxygen has a direct effect on the induction of
slpD expression or whether some other changes in environmental factors under these
conditions affect the control of slpD transcription. Most likely, a stress-related cascade
of events may be involved.
The further construction of an L. brevis ATCC 14869 S-layer protein antigen display
system has not yet been employed, since the phase variation responsible for the differential
expression of Slp proteins under diverse growth conditions has not yet been characterized
in detail. The phase variation observed in the Slp protein expression of ATCC 14869 in
addition to the observed limitation of ATCC 14869 to tolerate higher growth temperatures
do not encourage the use of this strain as an antigen delivery vector. Further
characterization of the binding specificity and the the binding domain may provide
additional possibilities to modify this function in L. brevis S-layer applications.
5.2. Surface display of model epitopes on the Lactobacillus brevis S-layer (II)
The large number of S-layer protein subunits present in an S-layer and the possibility to
detach the S-layer from the cell to a cell-free self-assembling S-layer protomer would
make the use of antigen display system based on a Lactobacillus S-layer an interesting
alternative to the other surface-display systems developed for lactobacilli. The S-layer
protein of L. brevis ATCC 8287 was chosen for this study due to its well-characterized
status. L. brevis strain ATCC 8287 is a possible candidate for a live mucosal antigen
delivery vector, since it has been shown to possess several properties required for a
probiotic bacterium (Rönkä et al., 2003) and it adheres to several types of human intestinal
epithelial cell (Hynönen et al., 2002), which may be beneficial in the elicitation of immune
responses to the antigen displayed by the L. brevis.
5.2.1. Construction of epitope-expressing L. brevis strains producing chimeric S-
layers
The four most hydrophilic parts determined from the hydrophilicity profile of the SlpA
protein of L. brevis ATCC 8287 were chosen to be used as epitope insertion sites and
were named as I to IV. The number of insertion sites to be tested was restricted due to the
fact that the L. brevis slpA gene contains a high amount of inverted and direct repeats
(Vidgrén et al., 1992), and it has been found to be very difficult to clone due to its
instability and toxicity in heterologous hosts. As model epitopes, an 11-aa
immunodominant region of the VP1 capsid protein of enteroviruses (Hovi and Roivainen,
1993) and a 10-aa c-Myc epitope (Evan et al., 1985) were used. Expression cassettes
carrying under the control of the nisA promoter the slpA gene and the VP1 epitope DNA
in slpA insertion sites I-IV and c-myc in insertion site II were constructed in L. lactis and
subsequently transferred into L. brevis, harboring pNZ9530 for nisin induction.
The surface accessibility of the model epitopes expressed by the nisin induced double-
plasmid strains was studied with whole-cell ELISA and immunofluore-scence microscopy
using anti-VP1 or anti-c-Myc antibodies. The results from the whole-cell ELISA assays
indicated that with insertion site II the best surface accessibility of the model epitopes
could be obtained and that also with insertion site I VP1 could be surface displayd. By
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immunofluorescence assays the surface display of the model epitopes could not be detected
in any of the double-plasmid strains, indicating a low expression level of epitopes in this
system. This was probably due to a much lower expression level of the epitope-SlpA
constructs under the nisA promoter compared to the high level expression of the
chromosomal slpA gene, which was still present in these double-plasmid strains. With
this nisin-inducible double-plasmid system a chimeric and active S-layer structure could
thus be obtained containing, however, only a few copies of the epitope-SlpA subunit.
5.2.2. Gene replacement of the native L. brevis slpA gene with the slpA-c-myc
fusion construct and characterization of the integrant strain GRL1046
To increase the expression level of the epitope-SlpA protein obtained with the double
plasmid L. brevis strains, several thermosensitive-integration vectors were tested to obtain
gene replacement by two subsequent single crossover events (data not shown). With
these vectors, a primary integration of the model epitopes to slpA could be demonstrated
but the transformants obtained turned out to be highly unstable (data not shown).
Development of a gene replacement system was also hampered by the lack of certainty
over whether the epitopes in the chosen insertion sites would be toxic or retard cell
growth when produced as part of a uniform S-layer. Finally, a gene replacement system
consisting of a pORI280 derivative pKTH5115 harboring c-myc in insertion site II and a
thermosensitive plasmid pVE6007 was chosen to be tested. This system was selected to
minimize the concomitant slpA transcription and plasmid replication functions in the L.
brevis chromosome, which are likely to result in DNA rearrangements. By supplying the
RepA protein in another plasmid, a tighter replication control can be achieved compared
to the direct thermosensitive-integration vectors, where the restrictive temperature in L.
brevis does not completely shut down the replication functions. This integration strategy
has been utilized previously in Lactococcus for the generation of chromosomal mutations
(Law et al., 1995), and a similar two plasmids system was recently modified for
Lactobacillus gasseri and Lactobacillus acidophilus to widen the applicable gene
inactivation temperatures (Russell and Klaenhammer, 2001).
 A transformant harboring pKTH5115 and pVE6007 was grown at a restrictive
temperature (39°C) under antibiotic selection to find clones with the pKTH5115 integrated
into the bacterial chromosome through homologous recombination between the wild-
type and c-myc-slpA. PCR and DNA-sequencing analysis of an erythromycin-resistant
and chloram-phenicol-sensitive strain, indicating the loss of pVE6007, verified a direct
double-crossover integration of c-myc into the L. brevis chromosome. However, by PCR-
analyses this strain, designated L. brevis GRL1045, was shown to also harbor the
unintegrated plasmid pKTH5115. A possible explanation for this was that the resident
plasmid of unknown function, harbored by L. brevis GRL1 (Rönkä et al., 2003), could
provide some residual replication function to pKTH5115. The final integrant strain
GRL1046, harboring no unintegrated pKTH5115, was obtained by culturing the GRL1045
for approximately 50 generations without antibiotics. The strain GRL1046 was further
characterized in detail with DNA sequencing and PCR analyses. The results from these
assays verified that the integrant strain GRL1046 harbored no unintegrated pKTH5115
and that the DNA region encoding the c-Myc epitope was located in insertion site II. A
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Southern hybridization with a slpA specific probe was also performed indicating that no
chromosomal rearrangements on the slpA gene region had occurred in strain GRL1046.
By whole-cell SDS-PAGE analyses from GRL1046 cells a single putative
recombinant S-layer protein band of 46 kDa with a slightly lower electrophoretic mobility
compared with that of native SlpA was detected. The exact molecular masses of of the
LiCl-isolated SlpA proteins of GRL1046 and GRL1 were determined by matrix-assisted
laser desorption ionization time-of-flight mass spectrometry and were found to be in
accordance with their calculated molecular masses. Whole-cell ELISA and
immunofluorescence microscopy with anti-Myc antibodies confirmed that the c-Myc
epitope was surface exposed in GRL1046. Transmission electron microscopy analyses
with LiCl-isolated S-layer proteins and cells from GRL1046 and GRL1 indicated that
the S-layer lattice symmetry or the self-assembly of isolated S-layer protein subunits
was not affected by the presence of c-Myc epitopes, since both L. brevis strains formed
an oblique structure. The negative staining technique only allowed visualization of
disrupted cells and isolated self-assembled S-layers because of the high staining
background of intact cells. To visualize the cell surface of intact L. brevis cells, the freeze-
etching technique and certain stainings in the thin-sectioning technique could be applied.
With these techniques, resolution problems could, however, arise due to the nature of
this S-layer and because it is superimposed with the irregular structures (e.g. the polymers)
of the cell wall.
Various recombinant Lactobacillus strains producing surface-exposed antigens have
been constructed and used in immunization experiments (Maassen et al., 1999; Reveneau
et al., 2002; Scheppler et al., 2002). On the surface of L. casei, approximately 1.4 – 3.9 ×
103 TTFC molecules have been produced with vectors driving the TTFC expression under
control of an α-amylase or L-(+)-lactate dehydrogenase promoter, respectively (Maassen
et al., 1999). It has been theoretically calculated that the encompassing S-layer on an
average size cell consists of approximately 5 x 105 monomers (Sleytr and Messner, 1988).
Thus, with the surface display system developed in this study, it is possible to present at
least such a high number of antigen epitope molecules on the cell surface of each L.
brevis cell. Surface displaying of vaccines as part of an S-layer would thus be a very
efficient method for presenting antigens to the mucosa-associated lymphoreticular tissue.
This study has thus shown that at least small epitopes can be successfully surface-displayed
as part of the S-layer protein of L. brevis, and that an intact S-layer without any changes
in the crystalline structure can be formed in spite of the presence of a heterologous epitope
in every S-layer subunit.
5.3. Surface expression of the SlpA receptor-binding region of L. brevis ATCC 8287
in nonadhesive lactococci (III)
The aim of this study was to determine whether a nonadhesive LAB can be provided
with a specific adhesion capability with the receptor-binding region of SlpA, mediating
adhesion to various epithelial cells of human origin. The transfer of adhesin molecules to
nonadherent LAB may be beneficial for several applications and it allows the study of
whether the delivery of a bioactive molecule of interest is affected by the change
concomitant with the adherence potential of the LAB vector.
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We chose 247 amino acids long N-terminal region, including the signal peptide of
30 residues, from the L. brevis SlpA protein for surface expression and adhesion studies
in L. lactis. This region was previously shown to include the receptor-binding region of
SlpA, which adheres to fibronectin and several human epithelial cell types, by using a
flagella display system in E. coli (Hynönen et al., 2002). With flagella display experiments
the binding domain of SlpA could be limited to up to 81-amino-acid residues representing
residues 96 through 176 in the unprocessed SlpA protein (Hynönen et al., 2002). L. lactis
was used as the host in this study for reasons including the following: this organism does
not adhere to Intestine 407 cells (Palva et al., unpublished results), a wide range of genetic
tools to study it are available, it has been successfully used for surface display of
heterologous proteins (Steidler et al., 1998; Bermúdez-Humarán et al., 2004; Mannam et
al., 2004,) and it is currently being developed as a mucosal delivery vehicle (Cheun et
al., 2004; Robinson et al., 2004).
To properly extend the SlpA receptor-binding region out of the cell surface, it was
decided to use parts of the L. lactis subsp. cremoris Wg2 prtP gene (Kok et al., 1988) as
spacers. The optimal size of the PrtP spacer was studied by constructing plasmids
pKTH5050 and 5051, which encode a fusion protein consisting of the AcmA signal peptide,
the mature β-lactamase (Bla), a PrtP spacer of 215 aa (pKTH 5050) or 515 aa (pKTH5051)
and the AcmA cell wall anchor. Whole-cell ELISA with anti-Bla antibodies indicated
that the surface accessibility of Bla was better with the PrtP spacer of 515 aa than with
the 215 aa spacer, so the 515 aa spacer was selected for use for the surface display of the
SlpA adhesion domain. The 515-amino-acid spacer, amplified from the C-terminus
encoding part of the prtP gene, spans the putative H-domain, and part of the W-domain
determined from the PrtP of L. lactis strain SK11 (Siezen, 1999). The function of the
putative H-domain has not been determined, but it has been suggested to act as a spacer
directing other PrtP domains further from the cell wall (Siezen, 1999). In putative H-
domains, alpha-helixes are the dominant secondary structure. Spacers consisting of alpha-
helixes of different length and origin have recently been used in enhancing the expression
of M6 protein on the cell surface of S. gordonii (Bolken et al., 2002).
Based on the surface display vector pNG101his, an expression cassette was
constructed that carries under the control of the nisA promoter the signal sequence of the
L. brevis slpA, the slpA adhesion-mediating region (aa 31 to 247), an L. lactis proteinase
(PrtP) spacer of 515 aa and the L. lactis AcmA cell wall-anchoring sequences (Buist,
1997). This construct was designated as pKTH5056 (Fig. 1 of III) and transferred into L.
lactis NZ9000.
Western blot analysis of lactococcal cell wall extracts with anti-SlpA antibodies
from nisin-induced L. lactis NZ9000 cells harboring pKTH5056 confirmed that the SlpA
adhesion domain of the fusion protein was expressed and located within the cell wall
layer. Whole-cell ELISA and immunofluorescence microscopy with anti-SlpA antibodies
were used in studying the surface accessibility of the SlpA adhesion-mediating region.
Both of these analyses confirmed that the pKTH5056-encoded SlpA receptor-binding
region was successfully displayed on the recombinant L. lactis cell surface.
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5.3.1. Adhesion of recombinant lactococci to Intestine 407 cells and human
plasma fibronectin in vitro
An in vitro adhesion assay using the human intestinal epithelial cell line Intestine 407,
derived from a small intestine of a 2-month-old human embryo (Henle and Deinhardt,
1957), indicated that nisin-induced recombinant L. lactis NZ000 harboring pKTH5056
possessed an approximately sevenfold [statistically significant (P < 0.01)] higher ability
to adhere to Intestine 407 cells than wild type NZ9000 cells. A statistically significant (P
< 0.01) increase in adherence to Intestine 407 cells between L. lactis NZ9000 cells
harboring pKHT5056 and pKTH5046, which lacks the SlpA adhesion domain, was also
observed. A serum inhibition assay further confirmed that adhesion of recombinant
lactococci to Intestine 407 cells was indeed mediated by the SlpA receptor-binding region
of the slpA gene. The S-layer protein of L. brevis ATCC 8287 has also been reported to
mediate binding to human fibronectin (Hynönen et al 2002), a structural glycoprotein
component of the extracellular matrix (Hay, 1981). The adhesion to immobilized
fibronectin of the recombinant L. lactis cells with pKTH5056 or pKTH5046 and the wild
type NZ9000 cells was tested. The results indicated an approximately sevenfold,
statistically significantly (P < 0.01) better ability of the nisin-induced recombinant L.
lactis with pKTH5056 to adhere to fibronectin compared to that of L. lactis with
pKTH5046 or all of the uninduced counterparts.
Even though a significant adhesion capacity to human epithelial Intestine 407 cells
could be provided to L. lactis host with the aid of the SlpA adhesion-mediating region,
the epithelial cell binding efficiency of L. lactis, harboring pKTH5056, was substantially
lower than that of the wild type L. brevis cells synthesizing a surface layer estimated to
be composed of approximately 0.5 million SlpA subunits (Palva et al., unpublished results;
Hynönen et al., 2002). One obvious explanation for this is that the quantity of pKTH5056
encoded SlpA molecules in L. lactis is approximately only a few percent of that present
in the native S-layer in L. brevis. We cannot, however, rule out that the receptor-binding
domain of SlpA also has a higher affinity in the S-layer conformation. The assumption
that entire S-layers possess more efficient binding capacity than their protein subunits is
supported also by the results from the expression studies of the collagen-binding CbsA
protein of L. crispatus in Lactobacillus casei. CbsA was anchored with the cell wall
sorting signal of PrtP to the cell wall and successfully expressed in L. casei, but no S-
layer was formed and the amount of collagen bound was lower than that observed with
wild type L. crispatus (Martínez et al., 2000).
In this study, an experimental approach to apply the receptor binding domain of the
L. brevis ATCC 8287 SlpA protein was demonstrated. LAB with an adhesion capability
could be utilized, for example, in the development of mucosal antigen delivery vehicles
or in targeting molecules/cells to a receptor of interest. The use of receptor-binding domains
of Lactobacillus origin may offer a safe alternative for the targeted delivery of various
effectors on mucosal membranes.
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5.4. Secretion of porcine interleukin-2 by Lactococcus lactis (IV)
Cytokines are currently being considered as vaccine adjuvants and several cytokines
have already been expressed in L. lactis. This study forms the basis for the construction
of an L. brevis vaccine vector strain co-expressing a cytokine adjuvant in addition to the
antigen.
In this study, our aim was to develop an inducible extracellular expression system
for porcine IL-2 protein in L. lactis. The IL-2 was chosen to be expressed in a secreted
form to obtain the rIL-2 proteins in a soluble form that would ease the purification of the
rIL-2 proteins with the Taghis6, and also ease the biological activity measurement. Moreover,
for the possible adjuvant use of porcine IL-2 expressed by L. lactis, a secreted form is
believed to be preferable to the other two possible cellular locations (intracellular or
surface displayed) of a heterologously expressed protein in L. lactis. All of the thus far
reported studies in which cytokines expressed by L. lactis have been used as adjuvants or
therapeutic agents have relied on extracellular production of the cytokine (Steidler et al.,
1998; 2000; 2003; Bermúdez-Humarán et al., 2003a), and the production of a cytokine
in a surface-displayed form in Lactococcus has not yet been described.
Two plasmid vectors for the extracellular expression of porcine IL-2 were constructed.
Total RNA of phytohemagglutinin stimulated PBMC was used as a template for the
amplification of IL-2 cDNA. The sequence encoding the mature IL-2 was cloned into a
pNZ8037 derivative vector giving rise to pKTH5186. In order to change the signal peptide
from that of the L. brevis slpA gene (SSslpA) (Vidgén et al., 1992) in pKTH5186 to the
signal peptide of L. lactis major secreted protein Usp45 (SSusp), the sequence encoding
mature IL-2 was further amplified from pKTH5186 and cloned into pKTH5146, giving
rise to plasmids pKTH5187 and pKTH5189 (Fig. 1 of IV). The expression cassette in
pKTH5187 consists of the SSusp, a synthetic sequence encoding the propeptide
LEISSTCDA (Le Loir et al., 1998), the sequence encoding mature porcine IL-2 and a
His-tag at the 3´ end, encoding rIL-protein designated as Proleiss-IL-2-Tag. The expression
cassette in pKTH5189 consists of the SSusp, a synthetic sequence encoding the propeptide
LEISSTSDA, the sequence encoding mature porcine IL-2, sequence encoding the putative
helix (H)-domain of PrtP of L. lactis (Siezen, 1999) and a His-tag at the 3´ end, resulting
in the expression Proleiss-IL-2-PrtP-Tag protein. The putative H-domain, included in the
spacer protein used in Study III, was cloned in pKTH5189 in order to study whether
additional sequences in the rIL-2 protein have any effect on folding and thus on the
biological activity of the rIL-2 fusion protein, anticipating the construction of  a surface-
displayed alternative of the IL-2. The L. lactis nisin promoter (PnisA) derived from
pKTH5146 was used for the inducible expression of both rIL-2 proteins.
Expression of the rIL-2 proteins was induced by the addition of nisin. Secreted rIL-
2 proteins carrying a histidine tag were purified from the concentrated supernatants of
induced L. lactis NZ9000 cells harboring pKTH5187 or pKTH5189 with a His Trap
column. With SDS-PAGE analysis bands corresponding to the expected molecular masses
of Proleiss-IL-2-Tag protein and Proleiss-IL-2-PrtP-Tag protein could be detected in purified
protein preparates.
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The secretion yields of the rIL-2 proteins were determined according to the protein
concentrations of the purified rIL-2 samples and were found to be quite similar for both
of the rIL-2 producer strains. L. lactis with pKTH5187 secreted approximately 0.58 µg/
ml Proleiss-IL-2-Tag and L. lactis with pKTH5189 secreted approximately 0.52 µg/ml
Proleiss-IL-2-PrtP-Tag. The putative H-domain of PrtP and the single amino acid substitution
from C to S in the propeptide LEISSTCDA, which were the only differences between the
Proleiss-IL-2-Tag protein and the Proleiss-IL-2-PrtP-Tag protein, thus did not seem to have
any major effects to the secretion efficiency of the Proleiss-IL-2-PrtP-Tag protein. The
propeptide LEISSTCDA has a net global negative charge of 2, which was not affected by
the amino acid substitution from C to S in the Proleiss-IL-2-PrtP-Tag protein. In this study
the effect of the Proleiss on the protein secretion efficiency was not studied, since an IL-2
expression cassette lacking the synthetic propeptide sequence was not constructed.
A Western blot analysis was performed to verify the specificity of the protein bands
detected with SDS-PAGE. The purified rIL-2 proteins Proleiss-IL-2-Tag and Proleiss-IL-2-
PrtP-Tag were blotted after separation by SDS-PAGE and probed with anti-porcine IL-2
antibodies. Bands of the expected molecular mass were detected for both of the rIL-2
proteins in the Western blot analysis, thus confirming that the rIL-2 proteins reacted
specifically with the antibodies raised against porcine IL-2. No background was observed
either in the SDS-PAGE or Western assays, indicating a successful purification with the
His trap column. The absence of breakdown products also indicates stability of the rIL-
2 proteins, although this was not experimentally studied.
5.4.1. The biological activity of rIL-2 proteins produced by L. lactis
The biological activity of both of the rIL-2 proteins was studied by a cell proliferation
assay using CTLL-2 cell line, which is dependent upon IL-2 for proliferation. A method
based on the bioreduction of a MTS tetrazolium compound into a coloured formazan
product was used for the measurement of cell proliferation. According to the average
results from two bioactivity assays, the specific biological activity of the Proleiss-IL-2-
Tag was determined to be approximately 2.2 × 107 U/µmol and the specific biological
activity of the Proleiss-IL-2-PrtP-Tag protein was determined to be approximately 1.8 ×
107 U/µmol. Hence, no substantial differences between the specific biological activities
of Proleiss-IL-2-Tag and Proleiss-IL-2-PrtP-Tag proteins were observed in this study. The
additional H-domain present in Proleiss-IL-2-PrtP-Tag protein thus did not seem to affect
the folding or conformation of the rIL-2 protein, demonstrating that additional sequences
can be included in porcine rIL-2 proteins without affecting the biological activity. These
results also encourage the development of a surface-displayed form of the porcine IL-2
in a chosen host strain.
This study thus showed that cytokines of porcine origin can also be produced in a
biologically active form in L. lactis and further developed and tested as adjuvants to be
used in immunizations with vaccines aimed at porcines.
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6. CONCLUSIONS AND FUTURE ASPECTS
This thesis describes the characterization of two new S-proteins and three new slp genes
from the L. brevis neotype strain ATCC 14869, the utilization of the S-layer protein or its
receptor-binding domain of L. brevis ATCC 8287 in applications related to more efficient
mucosal antigen delivery as well as the development of an expression system for a porcine
cytokine in L. lactis. This study was part of a larger project aimed at developing live oral
LAB vaccines. Advantages in employing LAB as vaccine vectors include the claimed
health-promoting properties (Vaughan et al., 1999) and the intrinsic adjuvant activities
(Seegers, 2002) possessed by several strains of LAB, the GRAS status of LAB (Adams
and Marteau, 1995) as well as the lack of lipopolysaccharides in the cell wall of LAB,
eliminating the risk of an endotoxic shock (Mercenier et al., 2000). L. brevis ATCC 8287
has potential to be used as a live antigen delivery vector due to its probiotic properties
(Rönkä et al., 2003) and capacity to adhere to human intestinal epithelial cells (Hynönen
et al., 2002). As the first target antigen to be expressed in L. brevis, the receptor binding
domain of the FedF adhesin of E. coli strains carrying F18 fimbriae will be employed in
our laboratory. F18 fimbrial E. coli strains cause porcine post-weaning diarrhea and
oedema disease that often are fatal to weaned pigs and are responsible for considerable
economic losses in the pig breeding industry (Verdonck et al., 2002). So far, commercial
vaccines against infections caused by the F18 fimbriae carrying E. coli strains are lacking.
By surface displaying epitopes or antigens as part of an S-layer, up to 5 × 105 epitope
monomers can be obtained to surround a single Lactobacillus cell, making such lactobacilli
very attractive candidates for mucosal vaccine delivery vectors. Due to the well-
characterized status of the S-layer protein of L. brevis ATCC 8287, the SlpA protein was
chosen to be further developed as an antigen carrier. Neither the S-layer lattice symmetry
nor the self-assembly of isolated S-layer were affected by the presence of the c-Myc
epitope in every S-layer subunit. As only the use of relatively short epitopes as part of the
L. brevis SlpA was tested, further characterization of the structural and functional domains
of SlpA is needed to determine whether larger antigens or epitopes can also be successfully
surface-displayed in the SlpA without effecting lattice self-assembly or symmetry. This
characterization will include the determination of amino acids crucial for the self-assembly
of the S-layer subunits as well as elucidation of the amino acids responsible for the
binding of the S-layer to the underlying cell wall. Identification of the location of amino
acid residues in the S-layer lattice will be studied in our laboratory by using site-directed
mutagenesis. Amino acids located preferentially on the outer surface of the S-layer and
in a location where the insertion does not affect the binding and assembly pattern of the
S-layer will subsequently be utilized as immunogen insertion sites.
Binding of the LAB vaccine vector to the mucosal membranes of the host may be an
advantage in general when the construction of a mucosally delivered vaccine is considered.
The S-layer protein of L. brevis ATCC 8287 performs as an adhesin mediating attachement
to various human epithelial cell types and fibronectin. Most likely the S-layer proteins
characterized from the L. brevis ATCC 14869 are also adhesins responsible for the adhesion
of this strain to porcine intestinal epithelial cells although this needs to be experimentally
confirmed. The two L. brevis strains characterized regarding their S-layer proteins show
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dissimilar binding affinities to epithelial cells of different origin (M. Jakava-Viljanen, A.
Palva, unpublished results; Hynönen et al., 2002). Thus it is relevant to obtain knowledge
of the binding domains of the L. brevis S-layer subunits. Future tasks hence include the
structural comparison of the S-layer binding regions in the Slp proteins of L. brevis,
which still awaits further data from the structure analyses planned for the S-layer proteins
of L. brevis. The functioning of the SlpA receptor-binding region was demonstrated in a
heterologous environment, demonstrating that receptor-binding regions of S-layer proteins
can be used as separate domains or entities apart from the S-layer context.
With an antigen providing the binding function to the epithelium, like the E. coli
F18 receptor-binding domain, the role of binding provided by the S-layer carrier molecule
may be of less importance. With an antigen having no binding capacity, the role of the S-
layer binding property to the epithelium may also become important, for example, for
the prevention of colonization of the invading pathogen by competitive exclusion in
addition to eliciting antibody responses against the pathogen. Further modification of the
S-layer binding properties, such as the generation of hybrid S-layer molecules with altered
binding domains, may also be required to match the demands of the chosen host animal
or tissue.
There is currently a need to identify new generation adjuvants also applicable to
mucosal immunization. By using cytokines as adjuvants the desired immunological effects,
specific for each cytokine, can be obtained and thus the selection of the appropriate
cytokine for each antigen plays a critical role. For the maximal induction of the mucosal
immune system an efficient adjuvant capable of enhancing and/or inducing the specific
mucosal immune responses to the co-administered vaccine antigen is often required.
Porcine IL-2 was produced in a biologically active form in L. lactis and can first be used
as an adjuvant in future immunizations aimed against infections caused by F18 fimbriae
carrying E. coli. Our future aims include the production of porcine IL-2 in a biologically
active form in L. brevis, either as a secreted form or a surface-displayed molecule.
Considering the putative use of IL-2 as a vaccine adjuvant, it also needs to be transferred
from the current nisin-inducible promoter under the regulation of a constitutive promoter
allowing continuous production of the cytokine.
Immunization studies with Lactobacillus S-layer antigen constructs are still lacking,
but the results of the few immunization studies utilizing recombinant S-layer proteins of
other bacteria (Umelo-Njaka et al., 2001; Riedmann et al., 2003) further encourage the
development of Lactobacillus S-layer based antigen carriers. Immunization studies with
piglets may be conducted with Lactobacillus vaccine vectors surface-displaying the
receptor-binding domain of E. coli F18 fimbriae as part of the S-layer and co-expressing
porcine cytokines as adjuvants.
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